<SEC-DOCUMENT>0001193125-20-269801.txt : 20201015
<SEC-HEADER>0001193125-20-269801.hdr.sgml : 20201015
<ACCEPTANCE-DATETIME>20201015071856
ACCESSION NUMBER:		0001193125-20-269801
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20201009
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201015
DATE AS OF CHANGE:		20201015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		201240313

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d102302d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mygn="http://imetrix.edgar-online.com/20201009" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-10-09_to_2020-10-09">MYRIAD GENETICS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-10-09_to_2020-10-09">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-10-09_to_2020-10-09">0000899923</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2020-10-09_to_2020-10-09" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2020-10-09_to_2020-10-09">--06-30</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="mygn-20201009.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-10-09_to_2020-10-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000899923</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-10-09</xbrli:startDate> <xbrli:endDate>2020-10-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-10-09_to_2020-10-09">8-K</ix:nonNumeric></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt:datemonthdayyearen">October&#160;9, 2020</ix:nonNumeric></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">MYRIAD GENETICS, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-10-09_to_2020-10-09">0-26642</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-10-09_to_2020-10-09">87-0494517</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-10-09_to_2020-10-09">320 Wakara Way</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-10-09_to_2020-10-09">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:stateprovnameen">Utah</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-10-09_to_2020-10-09">84108</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-10-09_to_2020-10-09">(801)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-10-09_to_2020-10-09">584-3600</ix:nonNumeric></span></p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see </span>General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-10-09_to_2020-10-09">Public Common Stock, $0.01 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-10-09_to_2020-10-09">MYGN</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-10-09_to_2020-10-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e)<span style="font-style:italic">&#160;Severance and Change in Control Agreement</span> </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;9, 2020, Myriad Genetics,&#160;Inc. (&#8220;Myriad&#8221; or the &#8220;Company&#8221;) adopted a new form of standard executive retention agreement (the &#8220;Severance and Change in Control Agreement&#8221;) for executive officers other than our Chief Executive Officer, whose arrangements with respect to severance and change in control of the Company are addressed in his employment agreement with us. The Severance and Change in Control Agreement replaced previous executive retention agreements with R.&#160;Bryan Riggsbee, Executive Vice President and Chief Financial Officer, our principal financial officer, and with named executive officers Jerry&#160;S. Lanchbury,&#160;Ph.D., Chief Scientific Officer, and Nicole Lambert, President of Myriad Women&#8217;s Health, Oncology and International. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of the Severance and Change in Control Agreement are intended to align our executive retention agreements more closely with prevailing market practices in our industry, and they differ from our prior executive retention agreements by, among other things: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">increasing the ownership threshold required for a change in control to 50%; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">replacing single-trigger accelerated vesting in a change in control with double-trigger vesting (both a change in control and termination are now required for accelerated vesting and cash severance benefits); </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reducing change in control severance payments from three times salary and bonus to one times salary and bonus; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">reducing medical benefits payments from 36 months to 12 months; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">introducing severance payments (one times salary and bonus) and equity acceleration (two years of vesting) upon a termination without &#8220;cause&#8221; or for &#8220;good reason&#8221; that is not in connection with a change in control. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the terms of the Severance and Change in Control Agreement, if the employment of an executive officer is terminated without &#8220;cause&#8221; or if the executive officer separates from Myriad for &#8220;good reason&#8221; (each as defined in the agreement), then the executive officer will receive: (i)&#160;an amount equal to the executive officer&#8217;s <span style="white-space:nowrap">then-current</span> annual base salary, an amount equal to the executive officer&#8217;s <span style="white-space:nowrap">then-current</span> target annual bonus, and any compensation previously deferred; (ii)&#160;a prorated portion of the executive officer&#8217;s target annual bonus for the <span style="white-space:nowrap">then-current</span> fiscal year, with such <span style="white-space:nowrap">pro-ration</span> based on the portion of the fiscal year worked prior to the separation date; (iii)&#160;immediate vesting of restricted stock units that are scheduled to vest within two years after termination; (iv)&#160;vesting of performance-based restricted stock units (&#8220;PSUs&#8221;) for two years following termination to the extent that the relevant performance metrics for the PSU grant are achieved; and (v)&#160;reimbursement for continued medical benefits until the earlier of 12 months after the date of termination or the date the executive officer begins employment with another employer. If the employment of an executive officer is terminated without &#8220;cause&#8221; or if the executive officer separates from Myriad for &#8220;good reason&#8221;, within three months before or 24 months after a &#8220;change in control&#8221; (as defined in the agreement), then the executive officer will receive the same benefits described in the preceding sentence, except that all outstanding and unvested equity grants will immediately vest in full. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Severance and Change in Control Agreement is qualified in its entirety by the full text of the Severance and Change in Control Agreement, which is filed as Exhibit&#160;10.1 to this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> (this <span style="white-space:nowrap">&#8220;Form&#160;8-K&#8221;)</span> and incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Amendment to 2017 Employee, Director and Consultant Equity Incentive Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;9, 2020, in connection with the adoption of the Severance and Change in Control Agreement for executive officers as described above, our Board of Directors (the &#8220;Board&#8221;) approved an amendment to Myriad&#8217;s 2017 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2017&#160;Plan&#8221;) to provide for an exception to the limitations on acceleration of vesting from the original grant vesting schedule when acceleration is otherwise </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided for in an employment agreement or other agreement with the Company, in addition to the cases of death, disability or change in control as previously provided for in the 2017 Plan. The foregoing description of the 2017 Plan, as amended, is qualified in its entirety by the full text of the 2017 Plan, which is filed as Exhibit&#160;10.2 to this <span style="white-space:nowrap">Form&#160;8-K</span> and incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.03</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&#160;On October&#160;9, 2020, the Board adopted amendments to Myriad&#8217;s <span style="white-space:nowrap">Restated&#160;By-Laws</span> (the <span style="white-space:nowrap">&#8220;By-Laws&#8221;)</span> to replace the plurality voting standard for uncontested director elections with a majority voting standard. The majority voting standard requires that a nominee receive a majority of the votes cast in an uncontested election to be elected or <span style="white-space:nowrap">re-elected</span> as director. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <span style="white-space:nowrap">By-Laws,</span> as amended, provide that if, in an uncontested election, an incumbent director does not receive a majority of the votes cast, such director must submit an irrevocable resignation to the Nominating and Governance Committee of the Board (the &#8220;Committee&#8221;). The Committee must make a recommendation to the Board as to whether to accept or reject the resignation of such incumbent director, or whether other action should be taken. The Board must act on the resignation, taking into account the Committee&#8217;s recommendation, and publicly disclose in a filing with the Securities and Exchange Commission (the &#8220;SEC&#8221;) its decision regarding the resignation within 90&#160;days following certification of the election results. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the amendments to the <span style="white-space:nowrap">By-Laws</span> is qualified in its entirety by the full text of the <span style="white-space:nowrap">By-Laws,</span> as amended, which is filed as Exhibit&#160;3.1 to this <span style="white-space:nowrap">Form&#160;8-K</span> and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&#160;On October&#160;9, 2020, pursuant to its authority under the <span style="white-space:nowrap">By-Laws,</span> the Board approved a change in Myriad&#8217;s fiscal year from a fiscal year ending on the last day of June&#160;of each year to a calendar fiscal year ending on the last day of December&#160;of each year, effective January&#160;1, 2021. Our transition plan for filing periodic reports with the SEC is to: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">for the <span style="white-space:nowrap">six-month</span> transition period from July&#160;1, 2020 through December&#160;31, 2020, file (i)&#160;a Quarterly Report on <span style="white-space:nowrap">Form&#160;10-Q</span> for the quarter ended September&#160;30, 2020 and (ii)&#160;an Annual Report on <span style="white-space:nowrap">Form&#160;10-KT</span> for the full transition period ending December&#160;31, 2020; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">beginning with calendar year 2021, file all periodic reports with the SEC on <span style="white-space:nowrap">Forms&#160;10-Q</span> and <span style="white-space:nowrap">10-K</span> on a calendar year basis. </p></td></tr></table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;15, 2020, we issued a press release announcing leadership, corporate governance and compensation initiatives, including adoption of a majority voting standard for uncontested director elections, a retirement process for directors and certain compensation updates, as well as our change to a calendar fiscal year. A copy of the press release is filed herewith as Exhibit&#160;99.1 and is incorporated herein by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d102302dex31.htm"><span style="white-space:nowrap">Restated&#160;By-Laws,</span> as of October&#160;9, 2020 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d102302dex101.htm">Form of Severance and Change in Control Agreement </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d102302dex102.htm">2017 Employee, Director and Consultant Equity Incentive Plan, as amended as of October&#160;9, 2020 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d102302dex991.htm">Press Release, dated October&#160;15, 2020 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibit(s) may contain hypertext links to information on our website or other parties&#8217; websites. The information on our website and other parties&#8217; websites is not incorporated by reference into this Current Report on <span style="white-space:nowrap">Form&#160;8-K</span> and does not constitute a part of this <span style="white-space:nowrap">Form&#160;8-K.</span> </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">MYRIAD GENETICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: October&#160;15, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ R. Bryan Riggsbee</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">R. Bryan Riggsbee</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Executive Vice President, Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d102302dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTATED <FONT STYLE="white-space:nowrap">BY-LAWS</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Amended and Restated October&nbsp;9, 2020) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE I&nbsp;-&nbsp;STOCKHOLDERS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Annual Meeting</U>. An annual meeting of the stockholders, for the election of directors to succeed those whose
terms expire and for the transaction of such other business as may properly come before the meeting, shall be held at such place, on such date, and at such time as the Board of Directors shall fix. The Board of Directors may, in its sole discretion,
determine that the meeting shall not be held at any place, but instead shall be held solely by means of remote communication as provided under the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Special Meetings</U>. Special meetings of the stockholders, for any purpose or purposes prescribed in the notice of
the meeting, may be called by the Board Chair, the Chief Executive Officer, the President (each only with the approval of the Executive Committee of the Board of Directors) or the Board of Directors by the affirmative vote of a majority of the Whole
Board (as defined below). Special meetings of the stockholders shall be held at such place, on such date, and at such time as shall be fixed by the Board of Directors or the person calling the meeting. The Board of Directors or the person calling
the meeting may, in its or his or her sole discretion, determine that the meeting shall not be held at any place, but instead shall be held solely by means of remote communication as provided under the Delaware General Corporation Law. The term
&#147;Whole Board&#148; as used herein shall mean the total number of authorized directors, whether or not there exists any vacancies in previously authorized directorships. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Notice of Meetings</U>. Written notice of the place, if any, date, and time of all meetings of the stockholders and
the means of remote communication, if any, shall be given, not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date on which the meeting is to be held, to each stockholder entitled to vote at such meeting, except as otherwise
provided herein or required by law (meaning, here and hereinafter, as required from time to time by the Delaware General Corporation Law or the Certificate of Incorporation of the Corporation, as amended and restated from time to time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a meeting is adjourned to another place, if any, date or time, written notice need not be given of the adjourned meeting if the place, if
any, date and time thereof are announced at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more than thirty (30)&nbsp;days after the date for which the meeting was originally noticed,
or if a new record date is fixed for the adjourned meeting, written notice of the place, if any, date, and time of the adjourned meeting shall be given in conformity herewith. At any adjourned meeting, any business may be transacted that might have
been transacted at the original meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U>Quorum</U>. At any meeting of the stockholders, the holders of a
majority of the voting power of the outstanding shares of the stock entitled to vote at the meeting present, in person or by proxy, shall constitute a quorum for all purposes, unless or except to the extent that the presence of a larger number may
be required by law or by rules of any stock exchange upon which the Corporation&#146;s securities are listed. Where a separate vote by a class or classes, or series thereof, is required, the holders of a majority of the voting power of the
outstanding shares of such class or classes, or series, present, in person or by proxy, shall constitute a quorum entitled to take action with respect to that vote on that matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a quorum shall fail to attend any meeting, the chair of the meeting may adjourn the meeting to another place, if any, date, or time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>Organization</U>. Such person as the Board of Directors may have designated or, in the absence of such a person, the
Board Chair, if any, or, in his or her absence, the Chief Executive Officer, if any, or, in his or her absence, the President, or, in his or her absence, such person as may be chosen by the holders of a majority of the shares entitled to vote who
are present, in person or by proxy, shall call to order any meeting of the stockholders and act as chair of the meeting. In the absence of the Secretary of the Corporation, the secretary of the meeting shall be such person as the chair of the
meeting appoints. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;6.</U> <U>Conduct of Business</U>. The chair of any meeting of stockholders shall determine the order
of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of discussion as may seem to him or her in order. The chair of the meeting shall have the power to adjourn the meeting to another place,
if any, date or time. The date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be announced at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;7.</U> <U>Notice of Stockholder Business and Nominations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>Annual Meetings of Stockholders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nominations of persons for election to the Board of Directors and the proposal of business to be considered by the stockholders may be made at
an annual meeting of stockholders (a)&nbsp;pursuant to the Corporation&#146;s notice of meeting / proxy materials with respect to such meeting, (b)&nbsp;by or at the direction of the Board of Directors or (c)&nbsp;by any stockholder of the
Corporation who was a stockholder of record at the time of giving of notice provided for in this Section, who is entitled to vote at the meeting and who complies with the notice procedures set forth in this Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>Special Meetings of Stockholders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only such business shall be conducted at a special meeting of stockholders as shall have been brought before the meeting pursuant to the
notice of meeting given pursuant to Section&nbsp;2 above. The notice of such special meeting shall include the purpose for which the meeting is called. Nominations of persons for election to the Board of Directors may be made at a special meeting of
stockholders at which directors are to be elected (a)&nbsp;by or at the direction of the Board of Directors or (b)&nbsp;provided that the Board of Directors has determined that directors shall be elected at such meeting, by any stockholder of the
Corporation who is a stockholder of record at the time of giving of notice of the special meeting, who shall be entitled to vote at the meeting and who complies with the notice procedures set forth in this Section. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>Certain Matters Pertaining to Stockholder Business and Nominations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) For nominations or other business to be properly brought before an annual meeting by a stockholder pursuant to Section&nbsp;7.A(c) of this
Article or a special meeting pursuant to Section&nbsp;7.B of this Article, (1)&nbsp;the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation, (2)&nbsp;such other business must otherwise be a proper matter
for stockholder action under Delaware law, (3)&nbsp;if the stockholder, or the beneficial owner on whose behalf any such proposal or nomination is made, has provided the Corporation with a Solicitation Notice, as that term is defined in
Section&nbsp;7.C(1)(c)(v) of this Article, such stockholder or beneficial owner must, in the case of a proposal, have delivered a proxy statement and form of proxy to holders of at least the percentage of the Corporation&#146;s voting shares
required under applicable law to carry any such proposal, or, in the case of a nomination or nominations, have delivered a proxy statement and form of proxy to holders of a percentage of the Corporation&#146;s voting shares reasonably believed by
such stockholder or beneficial holder to be sufficient to elect the nominee or nominees proposed to be nominated by such stockholder, and must, in either case, have included in such materials the Solicitation Notice, and (4)&nbsp;if no Solicitation
Notice relating thereto has been timely provided pursuant to this Section, the stockholder or beneficial owner proposing such business or nomination must not have solicited a number of proxies sufficient to have required the delivery of such a
Solicitation Notice under this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be timely, a stockholder&#146;s notice pertaining to an annual meeting shall be delivered to
the Secretary at the principal executive offices of the Corporation not later than the close of business on the sixtieth (60th)&nbsp;day nor earlier than the close of business on the ninetieth (90th)&nbsp;day prior to the first anniversary of the
date of the preceding year&#146;s annual meeting;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that in the event that the date of the annual meeting is more than thirty (30)&nbsp;days before or more than sixty (60)&nbsp;days after such an anniversary
date, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the ninetieth (90th)&nbsp;day prior to such annual meeting and not later than the close of business on the later of the sixtieth
(60th)&nbsp;day prior to such annual meeting or the close of business on the tenth (10th)&nbsp;day following the day on which public announcement of the date of such meeting is first made by the Corporation. Such stockholder&#146;s notice for an
annual meeting or a special meeting shall set forth </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) as to each person whom the stockholder proposes to nominate for election or
reelection as a director: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) all information relating to such person that is required to be disclosed in solicitations of proxies for
election of directors, or is otherwise required, in each case, pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) (including such person&#146;s written consent to being named in the proxy
statement as a nominee and to serving as a director if elected); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) a description of all direct and indirect compensation and other
material monetary agreements, arrangements and understandings during the past three years, and any other material relationships, between or among such stockholder and beneficial owner, if any, and their respective affiliates and associates, on the
one hand, and each proposed nominee, and his or her respective affiliates and associates, on the other hand, including, without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limitation all information that would be required to be disclosed pursuant to Item&nbsp;404 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated under the Securities Act of 1933,
as amended, if the stockholder making the nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof, were the &#147;registrant&#148; for purposes of such rule and the nominee were a
director or executive officer of such registrant, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) to the extent known by the stockholder, the name and address of any other
securityholder of the Corporation who owns, beneficially or of record, any securities of the Corporation and who supports any nominee proposed by such stockholder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv) with respect to each nominee for election or reelection to the Board of Directors, include a completed and signed questionnaire,
representation and agreement required by Section&nbsp;7.D(4) of this Article; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) as to any other business that the stockholder proposes
to bring before the meeting, a brief description of the business desired to be brought before the meeting, including the text of any resolutions proposed for consideration, the reasons for conducting such business at the meeting, any material
interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made, and to the extent known by the stockholder, the name and address of any other securityholder of the Corporation who owns,
beneficially or of record, any securities of the Corporation and who supports any matter such stockholder intends to propose; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) as
to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) the name
and address of such stockholder, as they appear on the Corporation&#146;s books, and of such beneficial owner; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) (A)&nbsp;the class
or series and number of shares of the Corporation which are, directly or indirectly, owned beneficially and of record by such stockholder and such beneficial owner, (B)&nbsp;any option, warrant, convertible security, stock appreciation right, or
similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the Corporation or with a value derived in whole or in part from the value of any class or series of
shares of the Corporation, whether or not such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the Corporation or otherwise (a &#147;Derivative Instrument&#148;) directly or indirectly owned
beneficially by such stockholder and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Corporation, (C)&nbsp;any proxy, contract, arrangement, understanding,
or relationship pursuant to which such stockholder has a right to vote any shares of any security of the Corporation, (D)&nbsp;any short interest in any security of the Corporation (for purposes of these
<FONT STYLE="white-space:nowrap">by-laws</FONT> a person shall be deemed to have a short interest in a security if such person directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has the opportunity
to profit or share in any profit derived from any decrease in the value of the subject security), (E)&nbsp;any rights to dividends on the shares of the Corporation owned beneficially by such stockholder that are separated or separable from the
underlying shares of the Corporation, (F)&nbsp;any proportionate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
interest in shares of the Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such stockholder is a general partner or, directly or
indirectly, beneficially owns an interest in a general partner, and (G)&nbsp;any performance-related fees (other than an asset-based fee) that such stockholder is entitled to based on any increase or decrease in the value of shares of the
Corporation or Derivative Instruments, if any, as of the date of such notice, including without limitation any such interests held by members of such stockholder&#146;s immediate family sharing the same household (which information shall be
supplemented by such stockholder and beneficial owner, if any, not later than ten (10)&nbsp;days after the record date for the meeting to disclose such ownership as of the record date; provided that if such date is after the date of the meeting, not
later than the day prior to the meeting); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) any other information relating to such stockholder and beneficial owner, if any, that
would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in a contested election pursuant to
Regulation 14A under the Exchange Act and the rules and regulations promulgated thereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv) a description of all agreements,
arrangements and understandings between such stockholder and beneficial owner, if any, and any other person or persons (including their names) in connection with the proposal of such business by such stockholder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v) a statement whether or not either such stockholder or beneficial owner intends to deliver a proxy statement and form of proxy to holders
of, in the case of a proposal, at least the percentage of the Corporation&#146;s voting shares required under applicable law to carry the proposal or, in the case of a nomination or nominations, a sufficient number of holders of the
Corporation&#146;s voting shares to elect such nominee or nominees (an affirmative statement of such intent, a &#147;Solicitation Notice&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) Notwithstanding anything in the second sentence of Section&nbsp;7.C(1) of this Article to the contrary, in the event that the number of
directors to be elected to the Board of Directors of the Corporation is increased and there is no public announcement by the Corporation naming all of the nominees for director or specifying the size of the increased Board of Directors at least
seventy (70)&nbsp;days prior to the first anniversary of the preceding year&#146;s annual meeting (or, if the annual meeting is held more than thirty (30)&nbsp;days before or sixty (60)&nbsp;days after such anniversary date, at least seventy
(70)&nbsp;days prior to such annual meeting), a stockholder&#146;s notice required by this Section shall also be considered timely, but only with respect to nominees for any new positions created by such increase, if it shall be delivered to the
Secretary at the principal executive office of the Corporation not later than the close of business on the tenth (10th)&nbsp;day following the day on which such public announcement is first made by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) In the event the Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board of
Directors, any such stockholder may nominate a person or persons (as the case may be), for election to such position(s) as specified in the Corporation&#146;s notice of meeting, if the stockholder&#146;s notice required by Section&nbsp;7.C(1) of
this Article shall be delivered to the Secretary at the principal executive offices of the Corporation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not earlier than the ninetieth (90th)&nbsp;day prior to such special meeting nor later than the close of business on the later of the sixtieth (60th)&nbsp;day prior to such special meeting, or
the tenth (10th)&nbsp;day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors to be elected at such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. <U>General</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) Only
such persons who are nominated in accordance with the procedures set forth in this Section shall be eligible to serve as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before the meeting
in accordance with the procedures set forth in this Section. Except as otherwise provided by law or these <FONT STYLE="white-space:nowrap">by-laws,</FONT> the chair of the meeting shall have the power and duty to determine whether a nomination or
any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in these <FONT STYLE="white-space:nowrap">by-laws</FONT> and, if any proposed nomination or business is not
in compliance herewith, to declare that such defective proposal or nomination shall be disregarded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) For purposes of this Section,
&#147;public announcement&#148; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable national news service or in a document publicly filed by the Corporation with the Securities and Exchange
Commission pursuant to Section&nbsp;13, 14 or 15(d) of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) Notwithstanding the foregoing provisions of this Section, a
stockholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this Section shall be deemed to affect any rights (i)&nbsp;of
stockholders to request inclusion of proposals in the Corporation&#146;s proxy statement pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act or (ii)&nbsp;of the holders of any series of Preferred Stock to elect
directors under specified circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) In addition to the requirements set forth elsewhere in these
<FONT STYLE="white-space:nowrap">by-laws,</FONT> to be eligible to be a nominee for election or reelection as a director of the Corporation, a person must deliver, in accordance with the time periods prescribed for delivery of notice under
Section&nbsp;7(C)(1) of this Article, to the Secretary of the Corporation at the principal executive offices of the Corporation a completed and signed questionnaire with respect to the background and qualification of such person and the background
of any other person or entity on whose behalf the nomination is being made (which questionnaire shall be provided by the Secretary upon written request) and a written representation and agreement (in the form provided by the Secretary upon written
request) that such person (i)&nbsp;is not and will not become a party to (A)&nbsp;any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a
director of the Corporation, will act or vote on any issue or question (a &#147;Voting Commitment&#148;) that has not been disclosed to the Corporation or (B)&nbsp;any Voting Commitment that could limit or interfere with such person&#146;s ability
to comply, if elected as a director of the Corporation, with such person&#146;s fiduciary duties under applicable law, (ii)&nbsp;is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than
the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
service or action as a director that has not been disclosed therein, and (iii)&nbsp;in such person&#146;s individual capacity and on behalf of any person or entity on whose behalf the nomination
is being made, would be in compliance, if elected as a director of the Corporation, and will comply with, applicable law and all applicable publicly disclosed corporate governance, code of conduct and ethics, conflict of interest, corporate
opportunities, trading and any other policies and guidelines of the Corporation applicable to directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) Notwithstanding the
foregoing provisions of this Section, unless otherwise required by law, if the stockholder (or a qualified representative of the stockholder) does not appear at the annual or special meeting of stockholders of the Corporation to make its nomination
or propose any other matter, such nomination shall be disregarded and such other proposed matter shall not be transacted, even if proxies in respect of such vote have been received by the Corporation. For purposes of this Section, to be considered a
&#147;qualified representative&#148; of the stockholder, a person must be a duly authorized officer, manager or partner of such stockholder or must be authorized by a writing executed by such stockholder or an electronic transmission delivered by
such stockholder to act for such stockholder as proxy at the meeting of stockholders, and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the commencement of
the meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section</U><U></U><U>&nbsp;8. Proxies and Voting</U>. At any meeting of the stockholders, every
stockholder entitled to vote may vote in person or by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting. Any copy, facsimile telecommunication or
other reliable reproduction of the writing or transmission created pursuant to this Section may be substituted or used in lieu of the original writing or transmission for any and all purposes for which the original writing or transmission could be
used, provided that such copy, facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All voting, including on the election of directors but excepting where otherwise required by law, may be by voice vote. Any vote not taken by
voice shall be taken by ballots, each of which shall state the name of the stockholder or proxy voting and such other information as may be required under the procedure established for the meeting. The Corporation may, and to the extent required by
law, shall, in advance of any meeting of stockholders, appoint one or more inspectors to act at the meeting and make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who
fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the person presiding at the meeting may, and to the extent required by law, shall, appoint one or more inspectors to act at the meeting. Each inspector, before
entering upon the discharge of his or her duties, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality and according to the best of his or her ability. Every vote taken by ballots shall be counted by a
duly appointed inspector or inspectors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise required by law, these <FONT STYLE="white-space:nowrap">by-laws</FONT> or the
rules of any stock exchange upon which the Corporation&#146;s securities are listed, all matters determined by stockholders at a meeting shall be determined by a majority of the votes cast affirmatively or negatively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;9.</U> <U>Stock List</U>. A complete list of stockholders entitled to vote
at any meeting of stockholders, arranged in alphabetical order for each class of stock and showing the address of each such stockholder and the number of shares registered in such stockholder&#146;s name, shall be open to the examination of any such
stockholder, for any purpose germane to the meeting, during ordinary business hours for a period of at least ten (10)&nbsp;days prior to the meeting in the manner provided by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock list shall also be open to the examination of any such stockholder during the whole time of the meeting as provided by law. This
list shall presumptively determine the identity of the stockholders entitled to examine such stock list and to vote at the meeting and the number of shares held by each of them. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE II&nbsp;-&nbsp;BOARD OF DIRECTORS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>General Powers, Number, Term of Office and Election</U>. The business and affairs of the Corporation shall be
managed by or under the direction of its Board of Directors. Subject to the rights of the holders of any class or series of Preferred Stock, the number of directors shall be fixed from time to time exclusively by the Board of Directors pursuant to a
resolution adopted by a majority of the Whole Board. The directors, other than those who may be elected by the holders of any class or series of Preferred Stock under specified circumstances, shall be divided into three classes, each having a term
of office to expire at the third succeeding annual meeting of stockholders after their election, with each director to hold office until his or her successor shall have been duly elected and qualified. At each annual meeting of stockholders,
(i)&nbsp;directors elected to succeed those directors whose terms expire shall be elected for a term of office to expire at the third succeeding annual meeting of stockholders after their election, with each director to hold office until his or her
successor shall have been duly elected and qualified, and (ii)&nbsp;if authorized by a resolution of the Board of Directors, directors may be elected to fill any vacancy on the Board of Directors, regardless of how such vacancy shall have been
created. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by these <FONT STYLE="white-space:nowrap">by-laws,</FONT> each director shall be elected by a
stockholder vote constituting a majority of the votes cast with respect to that director&#146;s election at any meeting for the election of directors at which a quorum is present, provided that if the number of nominees exceeds the number of
directors to be elected at such meeting (a &#147;contested election&#148;), the directors shall be elected by the vote of a plurality of the votes cast. For purposes of this Section&nbsp;1, &#147;a majority of the votes cast&#148; shall mean that
the number of votes cast &#147;for&#148; a director&#146;s election exceeds the number of votes cast &#147;against&#148; that director&#146;s election (with &#147;abstentions&#148; and &#147;broker
<FONT STYLE="white-space:nowrap">non-votes&#148;</FONT> not counted as a vote cast either &#147;for&#148; or &#147;against&#148; that director&#146;s election). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, in an election that is not a contested election, an incumbent director does not receive a majority of the votes cast, such director shall
submit an irrevocable resignation to the Nominating and Governance Committee, or such other committee designated by the Board of Directors pursuant to these <FONT STYLE="white-space:nowrap">by-laws.</FONT> Such committee shall make a recommendation
to the Board of Directors as to whether to accept or reject the resignation of such incumbent director, or whether other action should be taken. The Board of Directors shall act on the resignation, taking into account the committee&#146;s
recommendation, and publicly disclose (by filing an appropriate disclosure with the Securities and Exchange Commission) its decision regarding the resignation within ninety (90)&nbsp;days following certification of the election results. The
committee in making its recommendation and the Board of Directors in making its decision each may consider any factors and other information that they consider appropriate and relevant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Board of Directors accepts a director&#146;s resignation pursuant to this
Section&nbsp;1, or if a nominee for director is not elected and the nominee is not an incumbent director, then the Board of Directors may fill the resulting vacancy pursuant to Section&nbsp;2 of Article&nbsp;II of these <FONT
STYLE="white-space:nowrap">by-laws.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Vacancies and Newly Created Directorships</U>. Subject to the rights
of the holders of any class or series of Preferred Stock, and except as otherwise determined by the Board of Directors or required by law, newly created directorships resulting from any increase in the authorized number of directors or any vacancies
in the Board of Directors resulting from death, resignation, retirement, disqualification, removal from office or other cause may be filled only by a majority vote of the directors then in office, though less than a quorum, or the sole remaining
director (and not by stockholders); a director so chosen shall hold office for a term expiring at the annual meeting of stockholders at which the term of office of the class to which he or she has been elected expires, if applicable, and if no such
classes have been established or then exist, at the next annual meeting of stockholders and until such director&#146;s successor shall have been duly elected and qualified. In the event of any increase or decrease in the authorized number of
directors, (i)&nbsp;each director then serving as such shall nevertheless continue as a director of the class of which he or she is a member until the expiration of his or her current term or his or her prior death, retirement, removal or
resignation and (ii)&nbsp;the newly created or eliminated directorships resulting from such increase or decrease shall if reasonably possible be apportioned by the Board of Directors among the three classes of directors so as to ensure that no one
class has more than one director more than any other class. To the extent reasonably possible, consistent with the foregoing rule, any newly created directorships shall be added to those classes whose terms of office are to expire at the latest
dates following such allocation and newly eliminated directorships shall be subtracted from those classes whose terms of office are to expire at the earliest dates following such allocation, unless otherwise provided for from time to time by
resolution adopted by a majority of the directors then in office, although less than a quorum. No decrease in the number of authorized directors constituting the Board shall shorten the term of any incumbent director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Resignation</U>. Any director may resign by delivering a resignation in writing or by electronic transmission to the
Corporation at its principal place of business or to the Chief Executive Officer, President or Secretary. Such resignation shall be effective upon receipt unless it is specified to be effective at some other time or upon the happening of some other
event, including, in the case of a resignation delivered pursuant to Section&nbsp;1 of this Article II, upon the acceptance of such resignation by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U>Regular Meetings</U>. Regular meetings of the Board of Directors shall be held at such place or places, on such date
or dates, and at such time or times as shall have been established by the Board of Directors and publicized among all directors. A notice of each regular meeting shall not be required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>Special Meetings</U>. Special meetings of the Board of Directors
may be called by a majority of the Whole Board or by the Board Chair, if any, by the Chief Executive Officer, if a director, or by the President, if a director, and shall be held at such place, on such date, and at such time as they or he or she
shall fix. Notice of the place, date, and time of each such special meeting shall be given each director by whom it is not waived by mailing written notice not less than five (5)&nbsp;days before the meeting, by sending written notice by recognized
overnight courier service not less than two (2)&nbsp;days before the meeting or by telephone, telegraph, telex, facsimile or electronic transmission of the same not less than twenty-four (24)&nbsp;hours before the meeting. Unless otherwise indicated
in the notice thereof, any and all business may be transacted at a special meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;6.</U> <U>Quorum</U>. At any meeting
of the Board of Directors, a majority of the Whole Board shall constitute a quorum for all purposes. If a quorum shall fail to attend any meeting, a majority of those present may adjourn the meeting to another place, date, or time, without further
notice or waiver thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;7.</U> <U>Participation in Meetings by Conference Telephone</U>. Members of the Board of
Directors, or of any committee thereof, may participate in a meeting of the Board of Directors or committee by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each
other and such participation shall constitute presence in person at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;8.</U> <U>Conduct of Business</U>. At
any meeting of the Board of Directors, business shall be transacted in such order and manner as the Board of Directors may from time to time determine, and all matters shall be determined by the vote of a majority of the directors present, except as
otherwise provided herein or required by law. Action may be taken by the Board of Directors without a meeting if all members of the Board of Directors who are then in office consent thereto in writing or by electronic transmission, and the writing
or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the Board of Directors. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the
minutes are maintained in electronic form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;9.</U> <U>Powers</U>. The Board of Directors may, except as otherwise required
by law, exercise all such powers and do all such acts and things as may be exercised or done by the Corporation, including, without limiting the generality of the foregoing, the unqualified power: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(1) To declare dividends from time to time in accordance with law; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(2) To purchase or otherwise acquire any property, rights or privileges on such terms as it shall determine; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(3) To authorize the creation, making and issuance, in such form as it may determine, of written obligations of every kind, negotiable or <FONT
STYLE="white-space:nowrap">non-negotiable,</FONT> secured or unsecured, to borrow funds and guarantee obligations, and to do all things necessary in connection therewith; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(4) To remove any officer of the Corporation with or without cause, and from time to time to devolve the powers and duties of any officer upon
any other person for the time being; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(5) To confer upon any officer of the Corporation the power to appoint, remove and suspend
subordinate officers, employees and agents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(6) To adopt from time to time such stock option, stock purchase, bonus or other compensation
plans for directors, officers, employees and agents of the Corporation and its subsidiaries as it may determine; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(7) To adopt from time
to time such insurance, retirement, and other benefit plans for directors, officers, employees and agents of the Corporation and its subsidiaries as it may determine; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(8) To adopt from time to time regulations not inconsistent herewith, for the management of the Corporation&#146;s business and affairs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;10.</U> <U>Compensation of Directors</U>. Unless otherwise restricted by the certificate of incorporation, the Board of
Directors shall have the authority to fix the compensation of the directors. The directors may be paid their expenses, if any, of attendance at each meeting of the Board of Directors and may be paid a fixed sum for attendance at each meeting of the
Board of Directors or paid a stated salary or paid other compensation as director. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor. Members of special or standing
committees may be allowed compensation for attending committee meetings. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE III&nbsp;-&nbsp;COMMITTEES </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Committees of the Board of Directors</U>. The Board of Directors, by a vote of a majority of the Whole Board, may
from time to time designate committees of the Board of Directors, with such lawfully delegable powers and duties as it thereby confers, to serve at the pleasure of the Board of Directors and shall, for those committees and any others provided for
herein, elect a director or directors to serve as the member or members, designating, if it desires, other directors as alternate members who may replace any absent or disqualified member at any meeting of a committee. Any committee so designated
may exercise the power and authority of the Board of Directors to declare a dividend, to authorize the issuance of stock or to adopt a certificate of ownership and merger pursuant to Section&nbsp;253 of the Delaware General Corporation Law if the
resolution that designates the committee or a supplemental resolution of the Board of Directors shall so provide. In the absence or disqualification of any member of any committee and any alternate member in his or her place, the member or members
of the committee present at the meeting and not disqualified from voting, whether or not he or she or they constitute a quorum, may by unanimous vote appoint another member of the Board of Directors to act at the meeting in the place of the absent
or disqualified member. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Conduct of Business</U>. Each committee of the Board of Directors may determine the
procedural rules for meeting and conducting its business and shall act in accordance therewith, except as otherwise provided herein or required by law. Adequate provisions shall be made for notice to members of all meetings of committees. <FONT
STYLE="white-space:nowrap">One-third</FONT> (1/3)&nbsp;of the members of any committee shall constitute a quorum unless the committee shall consist of one (1)&nbsp;or two (2)&nbsp;members, in which event one (1)&nbsp;member shall constitute a
quorum; and all matters shall be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determined by a majority vote of the members present. Action may be taken by any committee without a meeting if all members thereof consent thereto in writing or by electronic transmission, and
the writing or writings or electronic transmission or transmissions are filed with the minutes of the proceedings of such committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if
the minutes are maintained in electronic form. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IV&nbsp;-&nbsp;OFFICERS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Generally</U>. The officers of the Corporation shall consist of a President, one or more Vice Presidents, a
Secretary, a Treasurer and such other officers as may from time to time be appointed by the Board of Directors, including, without limiting the generality of the foregoing, a Board Chair, a Chief Executive Officer, a Vice Board Chair and one or more
Assistant Secretaries and Assistant Treasurers. Officers shall be elected by the Board of Directors, which shall consider that subject at its first meeting after every annual meeting of stockholders. The Chief Executive Officer may be empowered to
appoint from time to time Vice Presidents, Assistant Secretaries and Assistant Treasurers. Each officer shall hold office until his or her successor is elected and qualified or if earlier, until he or she dies, resigns, is removed or becomes
disqualified, unless a shorter term is specified by the Board of Directors at the time of election of such officer. Any number of offices may be held by the same person. The salaries of officers elected by the Board of Directors shall be fixed from
time to time by the Board of Directors, a designated committee of the Board of Directors, or by such officers as may be designated by resolution of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Board Chair</U>. Unless otherwise provided by resolution of the Board of Directors, the Board Chair, if any, shall
preside at all meetings of the stockholders and all meetings of the Board of Directors at which he or she is present and shall have such authority and perform such duties as may be prescribed by these <FONT STYLE="white-space:nowrap">by-laws</FONT>
or from time to time determined by the Board of Directors. The Board Chair shall have power to sign all stock certificates, contracts and other instruments of the Corporation which are authorized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Vice Board Chair</U>. The Vice Board Chair, if any, shall have such powers and duties as may be delegated to him or
her by the Board of Directors. To the extent not otherwise provided herein, the Vice Board Chair shall perform the duties and exercise the powers of the Board Chair in the event of the Board Chair&#146;s absence or disability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U>Chief Executive Officer</U>. The Chief Executive Officer shall be the chief executive officer of the Corporation and
shall, subject to the direction of the Board of Directors, have the responsibility for the general management and control of the business and affairs of the Corporation. Unless otherwise provided by resolution of the Board of Directors, in the
absence of the Board Chair, if any, the Chief Executive Officer shall preside at all meetings of the stockholders and, if a director, meetings of the Board of Directors. The Chief Executive Officer shall have general supervision and direction of all
of the other officers (other than the Board Chair or any Vice Board Chair), employees and agents of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>President</U>. Except for meetings at which the Chief Executive
Officer or the Board Chair, if any, presides, the President shall, if present, preside at all meetings of stockholders, and if a director, at all meetings of the Board of Directors. The President shall, subject to the control and direction of the
Chief Executive Officer and the Board of Directors, have and perform such powers and duties as may be prescribed by these <FONT STYLE="white-space:nowrap">by-laws</FONT> or from time to time be determined by the Chief Executive Officer or the Board
of Directors. The President shall have power to sign all stock certificates, contracts and other instruments of the Corporation which are authorized. In the absence of a Chief Executive Officer, the President shall be the chief executive officer of
the Corporation and shall, subject to the direction of the Board of Directors, have the responsibility for the general management and control of the business and affairs of the Corporation and shall have general supervision and direction of all of
the officers (other than the Board Chair or any Vice Board Chair), employees and agents of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;6.</U>
<U>Vice President</U>. Each Vice President shall have such powers and duties as may be delegated to him or her by the Board of Directors, the Chief Executive Officer or the President. The Board of Directors may designate a Vice President to perform
the duties and exercise the powers of the President in the event of the President&#146;s absence or disability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;7.</U>
<U>Treasurer</U>. The Treasurer shall have the responsibility for maintaining the financial records of the Corporation. The Treasurer shall make such disbursements of the funds of the Corporation as are authorized and shall render from time to time
an account of all such transactions and of the financial condition of the Corporation. The Treasurer shall also perform such other duties as the Board of Directors may from time to time prescribe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;8.</U> <U>Secretary</U>. The Secretary shall issue all authorized notices for, and shall keep minutes of, all meetings of the
stockholders and the Board of Directors. The Secretary shall have charge of the corporate books and shall perform such other duties as the Board of Directors may from time to time prescribe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;9.</U> <U>Delegation of Authority</U>. The Board of Directors may from time to time delegate the powers or duties of any
officer to any other officers or agents, notwithstanding any provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;10.</U> <U>Removal</U>. Any officer of
the Corporation may be removed at any time, with or without cause, by the Board of Directors. Any officer elected or appointed by the Chief Executive Officer may be removed at any time by the Board of Directors or by the Chief Executive Officer.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;11.</U> <U>Resignation</U>. Any officer may resign by giving notice in writing or by electronic transmission of his or
her resignation to the Board Chair, if any, the Chief Executive Officer, if any, the President, or the Secretary, or to the Board of Directors Such resignation shall be effective upon receipt unless it is specified to be effective at some other time
or upon the happening of some other event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;12.</U> <U>Bond</U>. If required by the Board of Directors, any officer shall
give the Corporation a bond in such sum and with such surety or sureties and upon such terms and conditions as shall be satisfactory to the Board of Directors, including without limitation a bond for the faithful performance of the duties of his or
her office and for the restoration to the Corporation of all books, papers, vouchers, money and other property of whatever kind in his or her possession or under his or her control and belonging to the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;13.</U> <U>Action with Respect to Securities of Other Corporations</U>.
Unless otherwise directed by the Board of Directors, the President or the Chief Executive Officer or any officer of the Corporation authorized by the President or the Chief Executive Officer shall have power to vote and otherwise act on behalf of
the Corporation, in person or by proxy, at any meeting of stockholders of or with respect to any action of stockholders of any other corporation in which this Corporation may hold securities and otherwise to exercise any and all rights and powers
which this Corporation may possess by reason of its ownership of securities in such other corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE
V&nbsp;-&nbsp;INDEMNIFICATION OF DIRECTORS AND OFFICERS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Right to Indemnification</U>. Each person who was
or is made a party or is threatened to be made a party to or is otherwise involved (including, without limitation, as a witness) in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that
he or she is or was a director or an officer of the Corporation or a member of the Corporation&#146;s Scientific Advisory Board or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation,
or of a partnership, joint venture, trust or other enterprise, including service with respect to an employee benefit plan (hereinafter an &#147;Indemnitee&#148;), whether the basis of such proceeding is alleged action in an official capacity as a
director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by the Corporation to the fullest extent permitted by Delaware law, as the same exists or
may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than such law permitted the Corporation to provide prior to such amendment),
against all expense, liability and loss (including attorneys&#146; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such Indemnitee in connection therewith; provided, however,
that, except as provided in Section&nbsp;3 of this Article with respect to proceedings to enforce rights to indemnification or as otherwise required by law, the Corporation shall not be required to indemnify or advance expenses to any such
Indemnitee in connection with a proceeding (or part thereof) initiated by such Indemnitee unless such proceeding (or part thereof) was authorized by the board of directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Right to Advancement of Expenses</U>. In addition to the right to indemnification conferred in Section&nbsp;1 of
this Article, an Indemnitee shall also have the right to be paid by the Corporation the expenses (including attorney&#146;s fees) incurred in defending any such proceeding in advance of its final disposition; provided, however, that, if the Delaware
General Corporation Law requires, an advancement of expenses incurred by an Indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such Indemnitee, including, without
limitation, service to an employee benefit plan) shall be made only upon delivery to the Corporation of an undertaking, by or on behalf of such Indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial
decision from which there is no further right to appeal that such Indemnitee is not entitled to be indemnified for such expenses under this Section&nbsp;2 or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Right of Indemnitees to Bring Suit</U>. If a claim under
Section&nbsp;1 or 2 of this Article is not paid in full by the Corporation within sixty (60)&nbsp;days after a written claim has been received by the Corporation, except in the case of a claim for an advancement of expenses, in which case the
applicable period shall be twenty (20)&nbsp;days, the Indemnitee may at any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim. To the fullest extent permitted by law, if successful in whole or in part in
any such suit, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Indemnitee shall also be entitled to be paid the expenses of prosecuting or defending such suit. In
(i)&nbsp;any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the Indemnitee to enforce a right to an advancement of expenses) it shall be a defense that, and (ii)&nbsp;in any suit brought
by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the Indemnitee has not met any applicable standard for
indemnification set forth in the Delaware General Corporation Law. Neither the failure of the Corporation (including its directors who are not party to such action, a committee of such directors, independent legal counsel, or its stockholders) to
have made a determination prior to the commencement of such suit that indemnification of the Indemnitee is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in the Delaware General Corporation
Law, nor an actual determination by the Corporation (including its directors who are not party to such action, a committee of such directors, independent legal counsel, or its stockholders) that the Indemnitee has not met such applicable standard of
conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct or, in the case of such a suit brought by the Indemnitee, be a defense to such suit. In any suit brought by the Indemnitee to enforce a right to
indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or
to such advancement of expenses, under this Article or otherwise shall be on the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U><FONT
STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. The rights to indemnification and to the advancement of expenses conferred in this Article shall not be exclusive of any other right which any person may have or hereafter acquire
under any statute, the Corporation&#146;s Certificate of Incorporation as amended from time to time, these <FONT STYLE="white-space:nowrap">by-laws,</FONT> any agreement, any vote of stockholders or disinterested directors or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>Insurance</U>. The Corporation may maintain insurance, at its expense, to protect itself and any director, officer,
employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such
expense, liability or loss under the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;6.</U> <U>Indemnity Agreements</U>. The
Corporation may enter into indemnity agreements with the persons who are members of its Board of Directors from time to time, and with such officers, employees and agents of the Corporation and with such officers, directors, employees and agents of
subsidiaries as the Board of Directors may designate, such indemnity agreements to provide in substance that the Corporation will indemnify such persons as contemplated by this Article, and to include any other substantive or procedural provisions
regarding indemnification as are not inconsistent with Delaware law. The provisions of such indemnity agreements shall prevail to the extent that they limit or condition or differ from the provisions of this Article. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;7.</U> <U>Indemnification of Employees and Agents of the Corporation</U>.
The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest extent of the provisions of this
Article with respect to the indemnification and advancement of expenses of directors and officers of the Corporation and members of the Corporation&#146;s Scientific Advisory Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;8.</U> <U>Nature of Rights</U>. The rights conferred on Indemnitees in this Article shall be contract rights and such rights
shall continue as to an Indemnitee who has ceased to be a director, officer or trustee and shall inure to the benefit of the Indemnitee&#146;s heirs, executors and administrators. Any amendment, alteration or repeal of this Article that adversely
affects any right of an Indemnitee or its successors shall be prospective only and shall not limit, eliminate, or impair any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action or omission to act
that took place prior to such amendment or repeal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;9.</U> <U>Severability</U>. If any word, clause, provision or
provisions of this Article shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (i)&nbsp;the validity, legality and enforceability of the remaining provisions of this Article (including, without limitation, each portion
of any section of this Article containing any such provision held to be invalid, illegal or unenforceable, that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby; and (ii)&nbsp;to the
fullest extent possible, the provisions of this Article (including, without limitation, each such portion of any section of this Article&nbsp;containing any such provision held to be invalid, illegal or unenforceable) shall be construed so as to
give effect to the intent manifested by the provision held invalid, illegal or unenforceable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VI&nbsp;-&nbsp;STOCK </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Certificated and Uncertificated Stock</U>. Shares of the Corporation&#146;s stock may be certificated or
uncertificated, as provided under the General Corporation Law of the State of Delaware, and shall be entered in the books of the Corporation and registered as they are issued. Any certificates representing stock shall be in such form as the Board of
Directors shall prescribe, certifying the number and class of shares of the stock owned by the stockholder. Any certificates issued to a stockholder of the Corporation shall be signed by, or in the name of the Corporation by, the Board Chair or Vice
Board Chair, the President or a Vice President, and by the Secretary or an Assistant Secretary, or the Treasurer or an Assistant Treasurer. Any or all of the signatures on the certificate may be by facsimile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Transfers of Stock</U>. Transfers of stock shall be made only upon the transfer books of the Corporation kept at an
office of the Corporation or by transfer agents designated to transfer shares of the stock of the Corporation. Except where a certificate is issued in accordance with Section&nbsp;4 of this Article or in the case of uncertificated shares, an
outstanding certificate for the number of shares involved shall be surrendered for cancellation before a new certificate is issued therefor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Record Date</U>. In order that the Corporation may determine the
stockholders entitled to notice of any meeting of stockholders, or to receive payment of any dividend or other distribution or allotment of any rights or to exercise any rights in respect of any change, conversion or exchange of stock or for the
purpose of any other lawful action, the Board of Directors may fix a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which record date shall not be more than sixty (60)&nbsp;nor
less than ten (10)&nbsp;days before the date of any meeting of stockholders, nor more than sixty (60)&nbsp;days prior to the time for such other action as hereinbefore described. If the Board of Directors so fixes a date, such date shall also be the
record date for determining the stockholders entitled to vote at such meeting unless the Board of Directors determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such
determination. If no record date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of and to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on
which notice is given or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held, and, for determining stockholders entitled to receive payment of any dividend or other distribution or allotment
of rights or to exercise any rights of change, conversion or exchange of stock or for any other purpose, the record date shall be at the close of business on the day on which the Board of Directors adopts a resolution relating thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the
meeting; provided, however, that the Board of Directors may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case shall also fix as the record date for stockholders entitled to notice of
such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance with the foregoing provisions of this Section&nbsp;3 at the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U>Lost, Stolen or Destroyed Certificates</U>. In the event of the loss, theft or destruction of any certificate of
stock, another may be issued in its place pursuant to such regulations as the Board of Directors may establish concerning proof of such loss, theft or destruction and concerning the giving of a satisfactory bond or bonds of indemnity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>Regulations</U>. The issue, transfer, conversion and registration of shares of stock shall be governed by such other
regulations as the Board of Directors may establish. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VII&nbsp;-&nbsp;NOTICES </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Notices</U>. Except as otherwise specifically provided herein or required by law, all notices required to be given
to any stockholder, director, officer, employee or agent shall be in writing and may in every instance be effectively given by hand delivery to the recipient thereof, by depositing such notice in the mails, postage paid, or by sending such notice by
recognized courier service, prepaid telegram, telex, mailgram or by facsimile transmission or electronic transmission. Any such notice shall be addressed to such stockholder, director, officer, employee or agent at his or her last known address as
the same appears on the books of the Corporation. The time when such notice is received, if hand delivered, or dispatched, if delivered through the mails, by courier or by telegram, telex, facsimile transmission, electronic transmission or mailgram,
shall be the time of the giving of the notice. Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders may be given by electronic transmission in the manner provided in
Section&nbsp;232 of the Delaware General Corporation Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Waivers</U>. A written waiver or a waiver by electronic
transmission of any notice, signed by a stockholder, director, officer, employee or agent, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required to be given to such
stockholder, director, officer, employee or agent. Neither the business nor the purpose of any meeting need be specified in such a waiver. Attendance at any meeting shall constitute waiver of notice except attendance for the express purpose of
objecting at the beginning of the meeting to the transaction of business because the meeting is not lawfully called or convened. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VIII&nbsp;-&nbsp;MISCELLANEOUS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;1.</U> <U>Facsimile Signatures</U>. In addition to the provisions for use of facsimile signatures elsewhere specifically
authorized in these <FONT STYLE="white-space:nowrap">by-laws,</FONT> facsimile signatures of any officer or officers of the Corporation may be used whenever and as authorized by the Board of Directors or a committee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;2.</U> <U>Corporate Seal</U>. The Board of Directors may provide a suitable seal, containing the name of the Corporation,
which seal shall be in the charge of the Secretary. If and when so directed by the Board of Directors or a committee thereof, duplicates of the seal may be kept and used by the Secretary or Treasurer or by an Assistant Secretary or Assistant
Treasurer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;3.</U> <U>Reliance upon Books, Reports and Records</U>. Each director, each member of any committee designated
by the Board of Directors, and each officer of the Corporation shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation and upon such information,
opinions, reports or statements presented to the Corporation by any of its officers or employees or committees of the Board of Directors so designated, or by any other person as to matters which such director or committee member reasonably believes
are within such other person&#146;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;4.</U> <U>Fiscal Year</U>. The fiscal year of the Corporation shall be as fixed by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;5.</U> <U>Time Periods</U>. In applying any provision of these <FONT STYLE="white-space:nowrap">by-laws</FONT> that requires
that an act be done or not be done a specified number of days prior to an event or that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the doing of the act shall be excluded,
and the day of the event shall be included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;6.</U> <U>Pronouns</U>. Whenever the context may require, any pronouns used
in these <FONT STYLE="white-space:nowrap">by-laws</FONT> shall include the corresponding masculine, feminine or neuter forms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Section&nbsp;7.</U> <U>Exclusive Forum</U>. Unless the Corporation consents in writing to
the selection of an alternative forum, the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director or
officer or other employee of the Corporation to the Corporation or the Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim against the Corporation or any director or officer or other employee of the Corporation arising pursuant
to any provision of the Delaware General Corporation Law or the Certificate of Incorporation or these <FONT STYLE="white-space:nowrap">by-laws</FONT> (in each case, as they may be amended from time to time), or (iv)&nbsp;any action asserting a claim
against the Corporation or any director or officer or other employee of the Corporation governed by the internal affairs doctrine, shall be a state court located within the State of Delaware (or, if no state court located within the State of
Delaware has jurisdiction, the federal district court for the District of Delaware). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IX&nbsp;-&nbsp;AMENDMENTS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance and not in limitation of the powers conferred by law, the Board of Directors is expressly authorized to adopt, amend and repeal
these <FONT STYLE="white-space:nowrap">by-laws</FONT> subject to the power of the holders of capital stock of the Corporation to adopt, amend or repeal the <FONT STYLE="white-space:nowrap">by-laws;</FONT> provided, however, that, with respect to the
power of holders of capital stock to adopt, amend and repeal <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Corporation, notwithstanding any other provision of these <FONT STYLE="white-space:nowrap">by-laws</FONT> or any provision of law
which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the capital stock of the Corporation required by law, these
<FONT STYLE="white-space:nowrap">by-laws</FONT> or any Preferred Stock, the affirmative vote of the holders of at least seventy percent (70%)&nbsp;of the voting power of all of the then-outstanding shares entitled to vote generally in the election
of directors, voting together as a single class, shall be required to adopt, amend or repeal any provision of these <FONT STYLE="white-space:nowrap">by-laws.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d102302dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>SEVERANCE AND CHANGE IN CONTROL AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Severance and Change in Control Agreement (the &#147;<U>Agreement</U>&#148;) is made and entered into [DATE] (the &#147;<U>Effective
Date</U>&#148;), by and between Myriad Genetics, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), and [NAME] (&#147;<U>Employee</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee is currently employed by the Company under the terms of a separate employment agreement (the &#147;<U>Employment
Agreement</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Employee and the Company desire to enter into an agreement addressing severance generally as well as
severance in the specific circumstances of a Change of Control (as defined below) of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the
mutual promises, terms, provisions, and conditions contained herein, the parties agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Definition of &#147;Disability&#148;</U>. For purposes of this Agreement, &#147;<U>Disability</U>&#148; shall mean Employee&#146;s
inability to perform Employee&#146;s duties with the Company for one hundred twenty (120)&nbsp;days or more (cumulative or consecutive) within any twelve (12)&nbsp;month period as a result of Employee&#146;s physical or mental condition, subject to
documentation by a medical expert appointed by mutual agreement between the Company and Employee who has examined Employee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
<U>Definition of &#147;Cause&#148;</U>. As used herein, &#147;<U>Cause</U>&#148; shall mean: (i)&nbsp;Employee&#146;s gross negligence in the performance of Employee&#146;s duties to the Company; (ii)&nbsp;Employee&#146;s willful misconduct,
embezzlement, misappropriation, fraud, or professional dishonesty; (iii)&nbsp;Employee&#146;s material breach of any <FONT STYLE="white-space:nowrap">non-disclosure,</FONT> invention assignment,
<FONT STYLE="white-space:nowrap">non-competition,</FONT> or similar agreement between Employee and the Company; (iv)&nbsp;Employee&#146;s commission of a felony or of a crime involving moral turpitude; (v)&nbsp;Employee&#146;s willful and material
failure to comply with lawful directives of the Board; or (vi)&nbsp;Employee&#146;s willful and material breach of a material provision of any employment agreement between Employee and the Company or willful and material violation of a material
provision of any written Company employment policy applicable to its senior executive officers; <U>provided</U> that (A)&nbsp;the Company provides Employee with written notice that the Company intends to terminate Employee&#146;s employment
hereunder for one of the circumstances set forth in this Section&nbsp;1(b) within sixty (60)&nbsp;days of the Board&#146;s knowledge of such circumstance(s) occurring (which notice shall set forth in reasonable detail the circumstance(s) that the
Company alleges constitute(s) Cause), (B) in the event that a circumstance described in subsection (v)&nbsp;or (vi) is capable of being cured, Employee has failed to cure such circumstance within a period of thirty (30)&nbsp;days after the date of
receipt of such written notice, and (C)&nbsp;the Company terminates Employee&#146;s employment within sixty five (65)&nbsp;days from the date of the notice referred to in clause (A). Conduct shall not be considered &#147;willful&#148; unless done
(or omitted to be done) not in good faith and without a reasonable belief that such conduct (or lack thereof) was in the best interest of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Definition of &#147;Good Reason&#148;</U>. As used herein, &#147;<U>Good
Reason</U>&#148; shall mean: (i)&nbsp;a material diminution in Employee&#146;s duties, authority or responsibilities; (ii)&nbsp;a material diminution in Employee&#146;s Base Salary, other than a reduction of similar magnitude to the base salaries of
other Company senior executives if there is a reduction of Company senior executive base salaries generally, or a failure by the Company to provide the compensation and benefits provided for in this Agreement; or (iii)&nbsp;a material breach by the
Company of this Agreement or any other agreement between the Company and Employee; <U>provided</U> that (A)&nbsp;Employee provides the Company with written notice that Employee intends to terminate Employee&#146;s employment hereunder for one of the
circumstances set forth in this Section&nbsp;1(c) within sixty (60)&nbsp;days of such circumstance occurring (which notice shall set forth in reasonable detail the circumstance(s) that Employee alleges constitute(s) Good Reason), (B) if such
circumstance is capable of being cured, the Company has failed to cure such circumstance within a period of thirty (30)&nbsp;days after the date of receipt of such written notice, and (C)&nbsp;Employee terminates Employee&#146;s employment within
sixty five (65)&nbsp;days from the date of the notice referred to in clause (A). For purposes of clarification, the above-listed conditions shall apply separately to each occurrence of Good Reason, and failure to adhere to such conditions in the
event of a specific occurrence of Good Reason shall not disqualify Employee from asserting Good Reason for any subsequent occurrence of Good Reason. For purposes of this Agreement, &#147;Good Reason&#148; shall be interpreted in a manner, and
limited to the extent necessary, so that it shall not cause adverse tax consequences for either party with respect to Section&nbsp;409A (&#147;<U>Section</U><U></U><U>&nbsp;409A</U>&#148;) of the Internal Revenue Code of 1986, as amended (the
&#147;<U>Code</U>&#148;), and any successor statute, regulation and guidance thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Definition of &#147;Change of
Control&#148;</U>. As used herein, a &#147;<U>Change of Control</U>&#148; shall mean the occurrence of any of the following events: (A)<U>&nbsp;Ownership</U>: any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Securities
Exchange Act of 1934, as amended) becomes the &#147;Beneficial Owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or
more of the total voting power represented by the Company&#146;s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company, any subsidiary of the Company, or any employee benefit plan of the
Company); or (B)<U>&nbsp;Merger/Sale of Assets</U>: (1)&nbsp;a merger or consolidation of the Company whether or not approved by the Board, other than a merger or consolidation which would result in the voting securities of the Company outstanding
immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or the parent of such entity) at least fifty percent (50%) of the total voting power represented
by the voting securities of the Company or such surviving entity or parent of such entity, as the case may be, outstanding immediately after such merger or consolidation; or (2)&nbsp;the sale or disposition by the Company of all or substantially all
of the Company&#146;s assets; or (C)<U>&nbsp;Board Change</U>: a change in the Board or its members such that individuals who, as of the Effective Date or, if later, the date that is one year prior to such change (the later of such two dates
referred to herein as the &#147;<U>Measurement Date</U>&#148;), constitute the Board (the &#147;<U>Incumbent Board</U>&#148;) cease to constitute at least a majority of the Board; <U>provided</U>, however, that any individual becoming a director
subsequent to the Measurement Date whose election, or nomination for election by the Company&#146;s stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board (including for these purposes, any
new members whose election or nomination was so approved, without counting the member and his or her predecessor twice) shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such
individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a
person other than the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Payments upon Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Accrued Obligations</U>. Employee&#146;s employment is &#147;at will,&#148; meaning that Employee or the Company may terminate
Employee&#146;s employment at any time for any or no reason. In the event of the termination of Employee&#146;s employment for any reason, the Company shall pay Employee the &#147;<U>Accrued Obligations</U>,&#148; defined as: (i)&nbsp;the portion of
Employee&#146;s base salary that has accrued prior to any termination of Employee&#146;s employment with the Company and has not yet been paid (to be paid on or promptly after the date of termination of employment); (ii) any annual bonus previously
earned by Employee with respect to the fiscal year prior to the year in which separation occurs and not yet paid (to the extent such annual bonus would have been payable had Employee&#146;s employment with the Company continued and to be paid when
such annual bonus would have otherwise been paid had Employee&#146;s employment with the Company continued) (provided that this clause (ii)&nbsp;shall not apply, and shall not be included as a component of the Accrued Obligations, in the event of a
termination by the Company for Cause or by Employee without Good Reason); (iii) the amount of any expenses properly incurred by Employee on behalf of the Company prior to any such termination and not yet reimbursed (to be paid in the normal course);
and (v)&nbsp;Employee&#146;s entitlement to any other compensation or benefit under any retirement, health, welfare or other plan of the Company (which shall be governed by, and determined and paid in accordance with, the terms of the applicable
plan, except as otherwise specified in this Agreement). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Termination by the Company for Cause or by Employee without Good
Reason</U>. If Employee&#146;s employment is terminated by the Company for Cause or by Employee without Good Reason, then the Company shall pay the Accrued Obligations to Employee, and shall have no further payment or benefit obligation to Employee.
Without limiting the foregoing: (i)&nbsp;in the event of a termination by the Company for Cause, all vested and unvested equity grants automatically shall terminate and be forfeited; and (ii)&nbsp;in the event of a termination by Employee without
Good Reason, any unvested portion of equity grants automatically shall terminate and be forfeited, and Employee shall have no right to vest in or further acquire any portion of such unvested equity grant. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Termination by the Company without Cause, Disability or Death, or by Employee for Good Reason</U>. In the event that:
(i)&nbsp;Employee&#146;s employment is terminated by action of the Company other than for Cause, Disability or death, or (ii)&nbsp;Employee terminates Employee&#146;s employment for Good Reason, then, in addition to the Accrued Obligations, Employee
shall receive the following, subject to the terms and conditions of Section&nbsp;3(a): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Severance Payment</U>.
Payment in an amount equal to Employee&#146;s then-current base salary (provided that, in the event of a material diminution in base salary that qualifies as Good Reason, the base salary as used in this Section&nbsp;2(c)(i) shall be the base salary
immediately prior to such material diminution) plus Employee&#146;s then-current target amount of annual bonus, paid in one lump sum amount within sixty (60)&nbsp;days following Employee&#146;s last day of employment with the Company
(Employee&#146;s last day of employment with the Company, the &#147;<U>Separation Date</U>&#148;), less customary and required taxes and employment-related deductions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Severance
Bonus</U>. Payment in an amount equal to a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of Employee&#146;s then-current target amount of annual bonus for the fiscal year in which the Separation Date occurs (such <FONT
STYLE="white-space:nowrap">pro-ration</FONT> based on the portion of the fiscal year worked prior to the Separation Date), paid in one lump sum amount within sixty (60)&nbsp;days following the Separation Date, less customary and required taxes and
employment-related deductions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Equity Vesting</U>. Equity awards granted to Employee and outstanding immediately
prior to the Separation Date shall vest on the Separation Date to the extent scheduled to vest on or before the date two (2)&nbsp;years following the Separation Date. For purpose of determining the portion of equity awards that vest under this
Section&nbsp;2(c)(iii): (A) any annual vesting installments shall be deemed to vest in monthly installments over the applicable <FONT STYLE="white-space:nowrap">2-year</FONT> period (i.e., an equity award initially scheduled to vest in annual
installments over a <FONT STYLE="white-space:nowrap">two-year</FONT> period shall, for purposes of determining such acceleration, be considered to vest in twenty four (24)&nbsp;monthly installments over that same
<FONT STYLE="white-space:nowrap">two-year</FONT> period, and vesting shall include any fully-completed month within such <FONT STYLE="white-space:nowrap">2-year</FONT> period), and (B)&nbsp;any outstanding equity award with an unsatisfied
performance-based condition shall remain outstanding and, if the applicable performance condition is satisfied during such two (2)&nbsp;year period, shall, to the extent so earned, vest to the extent scheduled to vest within such <FONT
STYLE="white-space:nowrap">two-year</FONT> period upon satisfaction of such performance-based condition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <U>Benefits
Payments</U>. Upon completion of appropriate forms and subject to applicable terms and conditions under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), the Company shall pay or reimburse Employee
for the premiums charged to continue Employee&#146;s medical coverage pursuant to COBRA, at the same or reasonably equivalent medical coverage for Employee (and, if applicable, Employee&#146;s eligible dependents) as in effect immediately prior to
the Separation Date, until the earlier to occur of twelve (12)&nbsp;months following the Separation Date or the date Employee begins employment with another employer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Termination by the Company as a Result of Employee&#146;s Disability or Death</U>. In the event that Employee&#146;s employment
hereunder is terminated by the Company as a result of Employee&#146;s Disability or death, then, in addition to the Accrued Obligations, Employee (or Employee&#146;s estate as applicable) shall receive the following, subject to the terms and
conditions of Section&nbsp;3(a): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Severance Bonus</U>. Payment in
an amount equal to a <FONT STYLE="white-space:nowrap">pro-rata</FONT> portion of Employee&#146;s then-current target amount of annual bonus for the fiscal year in which the Separation Date occurs (such
<FONT STYLE="white-space:nowrap">pro-ration</FONT> based on the portion of the fiscal year worked prior to the Separation Date), paid in one lump sum amount within sixty (60)&nbsp;days following the Separation Date, less customary and required taxes
and employment-related deductions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U>Equity Vesting</U>. <FONT STYLE="white-space:nowrap">Pro-rata</FONT>
vesting of Employee&#146;s time-based equity awards based on the period of employment between the most recent vesting date prior to the Separation Date and the Separation Date, and including any time-based vesting of performance-based awards that
the Compensation Committee determines to have been earned based on achievement of applicable milestones prior to the Separation Date. For purpose of determining the portion of equity awards that vest under this Section&nbsp;2(d)(ii), any annual
vesting installments shall be deemed to vest in monthly installments over the applicable year of service (i.e., an equity award initially scheduled to vest in annual installments over a <FONT STYLE="white-space:nowrap">two-year</FONT> period shall,
for purposes of determining such acceleration, be considered to vest in twenty four (24)&nbsp;monthly installments over that same <FONT STYLE="white-space:nowrap">two-year</FONT> period, and vesting shall include any fully-completed month within
such <FONT STYLE="white-space:nowrap">2-year</FONT> period). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The severance payments and benefits described in Section&nbsp;2(d) shall not
be in addition to the severance payments and benefits described in Section&nbsp;2(c). In the event that Employee is eligible for the severance payments and benefits under Section&nbsp;2(d), Employee shall not be eligible for the severance payments
and benefits under Section&nbsp;2(c). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination by the Company other than for Cause, Disability or Death, or by Employee for Good
Reason, Following a Change of Control</U>. In the event that a Change of Control (as defined below) occurs, and within a period of three (3)&nbsp;months prior to, upon, or within twenty four (24)&nbsp;months following a Change of Control, either:
(i)&nbsp;Employee&#146;s employment is terminated by the Company other than for Cause, Disability or death, or (ii)&nbsp;Employee terminates Employee&#146;s employment for Good Reason, then, in addition to the Accrued Obligations, Employee shall
receive the following, subject to the terms and conditions in Section&nbsp;3(a): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Severance Payment</U>. Employee
shall receive the severance payment described in Section&nbsp;2(c)(i), subject to the terms and conditions described therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <U><FONT STYLE="white-space:nowrap">Pro-Rata</FONT> Severance Bonus</U>. Employee shall receive the severance bonus
described in Section&nbsp;2(c)(ii), subject to the terms and conditions described therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <U>Equity</U>. All equity
awards granted to Employee and outstanding on the date of termination shall immediately accelerate and vest, subject to the terms of any applicable equity plan and equity agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <U>Benefits Payments</U>. Employee shall receive the benefits payments described in Section&nbsp;2(c)(iv), subject to the
terms and conditions described therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The severance payments and benefits described in Section&nbsp;2(e) shall not be in addition to the
severance payments and benefits described in Section&nbsp;2(c). In the event that Employee is eligible for the severance payments and benefits under Section&nbsp;2(e), Employee shall not be eligible for the severance payments and benefits under
Section&nbsp;2(c). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Conditions on Termination Payments under Section</U><U></U><U>&nbsp;2</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Separation Agreement; Timing of Severance Benefits</U>. Provision of any severance payments, benefits, and equity described in Sections
2(c), 2(d) and 2(e) (collectively &#147;<U>Severance Benefits</U>&#148;) is expressly conditioned on Employee&#146;s execution without revocation of a separation agreement in a form acceptable to the Company, which shall include a release of claims
and standard terms regarding <FONT STYLE="white-space:nowrap">non-disparagement,</FONT> confidentiality, continuation of covenants, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cooperation and the like (the &#147;<U>Separation Agreement</U>&#148;). The Separation Agreement shall be provided to Employee within ten (10)&nbsp;days following separation from service and be
signed and irrevocable no later than sixty (60)&nbsp;days following Employee&#146;s separation from service. The Company shall commence payment of Severance Benefits on the next regular payroll date following the date on which the Separation
Agreement becomes signed and irrevocable, <U>provided</U> that: (i)&nbsp;if the <FONT STYLE="white-space:nowrap">60-day</FONT> period during which the Separation Agreement is required to become signed and irrevocable crosses a tax year, then
provision of the Severance Benefits shall be delayed until the second tax year; (ii)&nbsp;if applicable, the first payment of the Severance Benefit shall include all amounts that the Company would otherwise have paid to Employee between the date on
which the termination of Employee&#146;s employment became effective and the date of the first payment; and (iii)&nbsp;equity awards included in the Severance Benefits shall vest on the date in such <FONT STYLE="white-space:nowrap">60-day</FONT>
period that the Separation Agreement becomes signed and irrevocable, <U>provided</U> if the <FONT STYLE="white-space:nowrap">60-day</FONT> period during which the Separation Agreement is required to become signed and irrevocable crosses a tax year,
then such equity awards shall vest on the later of the date the Separation Agreement becomes signed and irrevocable and January&nbsp;1 of the second tax year. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>COBRA</U>. If the payment of any COBRA or health insurance premiums by the Company on behalf of Employee as described herein would
otherwise violate any applicable nondiscrimination rules or cause the reimbursement of claims to be taxable under the Patient Protection and Affordable Care Act of 2010, together with the Health Care and Education Reconciliation Act of 2010
(collectively, the &#147;<U>Act</U>&#148;) or Section&nbsp;105(h) of the Code, the COBRA premiums paid by the Company shall be treated as taxable payments (subject to customary and required taxes and employment-related deductions) and be subject to
imputed income tax treatment to the extent necessary to eliminate any discriminatory treatment or taxation under the Act or Section&nbsp;105(h) of the Code. If the Company determines in its reasonable discretion that it cannot provide the COBRA
benefits described herein under the Company&#146;s health insurance plan without violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Employee a
taxable lump sum payment in an amount equal to the sum of the monthly (or then remaining) COBRA premiums that Employee would be required to pay to maintain Employee&#146;s group health insurance coverage in effect on the Separation Date for the
remaining portion of the period for which Employee shall receive the payments described in Sections 2(c) or 2(e) above, and subject to Section&nbsp;3(a) above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Forfeiture/Clawback</U>. The compensation described in this Agreement shall be subject to any forfeiture or clawback policy established
by the Company generally for employees from time to time, including to the extent the forfeiture or clawback is required by the Sarbanes-Oxley Act of 2002 or other applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Property and Records</U>. Upon the termination of Employee&#146;s employment for any reason, or if the Company otherwise requests,
Employee shall: (a)&nbsp;return to the Company all Company confidential information and copies thereof (regardless of how such confidential information or copies are maintained) then in Employee&#146;s possession; and (b)&nbsp;deliver to the Company
any property of the Company which may be in Employee&#146;s possession, including, but not limited to, cell phones, smart phones, laptops, products, materials, memoranda, notes, records, reports or other documents or photocopies of the same;
provided that Employee may retain copies of applicable benefit plans, contracts to which Employee personally (<I>i.e.</I>, not in Employee&#146;s capacity as a Company employee) is a party, and Employee&#146;s personal contacts, calendars, and
correspondence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Certification Regarding Conflicting Obligations</U>. Employee hereby represents and
warrants that the execution of this Agreement and the performance of Employee&#146;s obligations hereunder shall not breach or be in conflict with any other agreement to which Employee is a party or is bound, or any other obligation or undertaking
of Employee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Taxation</U>. All compensation, payments and benefits provided to Employee hereunder shall be subject to applicable and
customary withholdings and deductions as required under law, statute, regulation, rule or term of any employee benefit plan in which Employee participates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Code Section</U><U></U><U>&nbsp;409A</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Employee acknowledges and agrees that the Company does not guarantee the tax treatment or tax consequences associated with any payment or
benefit arising under this Agreement, including but not limited to consequences related to Code Section&nbsp;409A. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that
the payments or benefits set forth in Section&nbsp;2 of this Agreement constitute <FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; subject to Code Section&nbsp;409A, then the following conditions apply to such
payments or benefits: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Any termination of Employee&#146;s employment triggering payments or benefits under
Section&nbsp;2 must constitute a &#147;separation from service&#148; under Section&nbsp;409A(a)(2)(A)(i) of the Code and Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.409A-1(h)</FONT> before distribution of such benefits can commence. To the
extent that the termination of Employee&#146;s employment does not constitute a separation of service under Section&nbsp;409A(a)(2)(A)(i) of the Code and Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.409A-1(h)</FONT> (as the result of further
services that are reasonably anticipated to be provided by Employee to the Company at the time Employee&#146;s employment terminates), any such payments under Section&nbsp;2 that constitute deferred compensation under Code Section&nbsp;409A shall be
delayed until after the date of a subsequent event constituting a separation of service under Section&nbsp;409A(a)(2)(A)(i) of the Code and Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.409A-1(h).</FONT> For purposes of clarification, this
Section&nbsp;6(b) shall not cause any forfeiture of benefits on Employee&#146;s part, but shall only act as a delay until such time as a &#147;separation from service&#148; occurs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding any other provision with respect to the timing of payments under Section&nbsp;2 if, on the date of
termination of Employee&#146;s employment, Employee is deemed to be a &#147;specified employee&#148; of the Company (within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code), then limited only to the extent necessary to comply with the
requirements of Code Section&nbsp;409A, any payments to which Employee may become entitled under Section&nbsp;2 which are subject to Code Section&nbsp;409A (and not otherwise exempt from its application) shall be withheld until the first (1<SUP
STYLE="font-size:85%; vertical-align:top">st</SUP>) business day of the seventh (7<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) month following the termination of Employee&#146;s employment, at which time Employee shall be paid an
aggregate amount equal to the accumulated, but unpaid, payments or benefits otherwise due to Employee under the terms of Section&nbsp;2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is intended that each installment of the payments and benefits provided under
Section&nbsp;2 of this Agreement shall be treated as a separate &#147;payment&#148; for purposes of Code Section&nbsp;409A. Neither the Company nor Employee shall have the right to accelerate or defer the delivery of any such payments or benefits
except to the extent specifically permitted or required by Code Section&nbsp;409A. Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall be interpreted and at all times administered in a manner that avoids the
inclusion of compensation in income under Code Section&nbsp;409A, or liability for increased taxes, excise taxes or other penalties under Code Section&nbsp;409A. The parties intend this Agreement to be in compliance with Code Section&nbsp;409A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Code Section</U><U></U><U>&nbsp;280G</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If any payment or benefit Employee would receive under this Agreement, when combined with any other payment or benefit Employee receives
pursuant to a Change of Control (for purposes of this section, a &#147;<U>Payment</U>&#148;) would constitute a &#147;parachute payment&#148; within the meaning of Code Section&nbsp;280G and, but for this sentence, be subject to the excise tax
imposed by Code Section&nbsp;4999 (the &#147;<U>Excise Tax</U>&#148;), then such Payment shall be either: (i)&nbsp;the full amount of such Payment; or (ii)&nbsp;such lesser amount (a &#147;<U>Reduced Payment</U>&#148;) as would result in no portion
of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employment taxes, income taxes and the Excise Tax, results in Employee&#146;s receipt, on an <FONT
STYLE="white-space:nowrap">after-tax</FONT> basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) With respect to Section&nbsp;7(a), if there is more than one method of reducing the Reduced Payment amount that would result in no portion
of the Payment being subject to the Excise Tax, then the Payment shall be reduced or eliminated in the following order: (i)&nbsp;cash payments; (ii)&nbsp;taxable benefits; (iii)&nbsp;nontaxable benefits; and (iv)&nbsp;accelerated vesting of equity
awards in a manner that maximizes the amount to be received by Employee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The determination of whether Section&nbsp;7(a)(i) or
(ii)&nbsp;applies, and the calculation of the amount of the Reduced Payment if applicable, shall be performed by a nationally recognized certified public accounting firm as may be designated by the Company (the &#147;<U>Accounting Firm</U>&#148;).
The Accounting Firm shall provide detailed supporting calculations to both the Company and Employee within fifteen (15)&nbsp;business days of the receipt of notice from Employee that there has been a Payment, or such earlier time as is requested by
the Company, in a form that can be relied upon for tax filing purposes. All fees and expenses of the Accounting Firm shall be borne solely by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Employee may receive a Payment that is, in the aggregate, either more or less than the amount described in Section&nbsp;7(a)(i) or (ii) (as
applicable, an &#147;<U>Overpayment</U>&#148; or &#147;<U>Underpayment</U>&#148;). If it is finally determined by a court of competent jurisdiction pursuant to a final <FONT STYLE="white-space:nowrap">non-appealable</FONT> judgment, or the Internal
Revenue Service, or by the Accounting Firm upon request by either the Company or Employee, that an Overpayment or Underpayment has been made, then: (i)&nbsp;in the event of an Overpayment, Employee shall promptly repay the Overpayment to the
Company, together with interest on the Overpayment at the applicable federal rate from the date of Employee&#146;s receipt of such Overpayment until the date of such repayment; and (ii)&nbsp;in the event of an Underpayment, the Company shall
promptly pay an amount equal to the Underpayment to Employee, together with interest on such amount at the applicable federal rate from the date such amount would have been paid to Employee had the provisions of Section&nbsp;7(a)(ii) not been
applied until the date of payment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>General</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Notices</U>. Except as otherwise specifically provided herein, any notice required or permitted by this Agreement shall be in writing
and shall be delivered as follows with notice deemed given as indicated: (i)&nbsp;by personal delivery when delivered personally; (ii)&nbsp;by overnight courier upon written verification of receipt; or (iii)&nbsp;by certified or registered mail,
return receipt requested, upon verification of receipt. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Notices to Employee shall be sent to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>The last known address in the Company&#146;s records or such other address as Employee may specify in writing. </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Notices to the Company shall be sent to: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Myriad Genetics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">320 Wakara
Way </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Salt Lake City, Utah 84108 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: General Counsel or, in the case of notices from General Counsel to the Company, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Chair </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><I>or to such other
the Company representative as the Company may specify in writing. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Modifications; Amendments; Waivers; Consents</U>. The terms
of this Agreement may be modified or amended only by written agreement executed by the parties hereto. The terms of this Agreement may be waived, or consent for the departure therefrom granted, only by a written document executed by the party
entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms of this Agreement, whether or not similar. Each such waiver or consent
shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Assignment</U>. The Company shall require any successor to all or substantially all of the Company&#146;s business and/or assets to
assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. Employee may not assign Employee&#146;s rights and obligations under
this Agreement without the prior written consent of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Governing Law; Jurisdiction; Venue</U>. This Agreement shall be
governed by and construed in accordance with the substantive laws of the State of Utah, without giving effect to any choice or conflict of law provision or rule. Any legal action permitted by this Agreement to enforce an award or for a claimed
breach shall be governed by the laws of the State of Utah, and shall be commenced and maintained solely in any state or federal court located in the State of Utah, and both parties hereby submit to the jurisdiction and venue of any such court. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Headings and Captions</U>. The headings and captions of the various subdivisions of
this Agreement are for convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Entire Agreement</U>. This Agreement, together with any other agreements specifically referenced herein, embodies the entire agreement
and understanding between the parties hereto with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or
agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Severability</U>. The invalidity or unenforceability of any provision of this Agreement will not affect the validity or enforceability
of any other provision of this Agreement, and this Agreement will be construed as if such invalid or unenforceable provision were omitted (but only to the extent that such provision cannot be appropriately reformed or modified). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Not Employment Contract</U>. Employee acknowledges that this Agreement does not constitute a contract of employment, does not imply that
the Company will continue Employee&#146;s employment for any period of time, does not change the <FONT STYLE="white-space:nowrap">at-will</FONT> nature of Employee&#146;s employment, and does not supersede the Employment Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. For all purposes an electronic signature shall be treated as an original. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Follow] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first
written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">EMPLOYEE</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">MYRIAD GENETICS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>d102302dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MYRIAD GENETICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2017 EMPLOYEE, DIRECTOR AND CONSULTANT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AS
AMENDED (October 9, 2020) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>DEFINITIONS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Myriad Genetics, Inc. 2017 Employee,
Director and Consultant Equity Incentive Plan, as amended, have the following meanings: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Administrator</U> means the Board of Directors,
unless it has delegated power to act on its behalf to the Committee, in which case the term Administrator means the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Affiliate</U> means a corporation which, for purposes of Section&nbsp;424 of the Code, is a parent or subsidiary of the Company, direct or
indirect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Agreement</U> means an agreement between the Company and a Participant delivered pursuant to the Plan and pertaining to a
Stock Right, in such form as the Administrator shall approve. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Board of Directors</U> means the Board of Directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Cause</U> means, with respect to a Participant (a)&nbsp;dishonesty with respect to the Company or any Affiliate, (b)&nbsp;insubordination,
substantial malfeasance or non-feasance of duty, (c)&nbsp;unauthorized disclosure of confidential information, (d)&nbsp;breach by a Participant of any provision of any employment, consulting, advisory, nondisclosure,
<FONT STYLE="white-space:nowrap">non-competition</FONT> or similar agreement between the Participant and the Company or any Affiliate, and (e)&nbsp;conduct substantially prejudicial to the business of the Company or any Affiliate; provided, however,
that any provision in an agreement between a Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede this definition with
respect to that Participant. The determination of the Administrator as to the existence of Cause will be conclusive on the Participant and the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Change of Control</U> means the occurrence of any of the following events: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Ownership</I>. Any &#147;Person&#148; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act)
becomes the &#147;Beneficial Owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented
by the Company&#146;s then outstanding voting securities (excluding for this purpose any such voting securities held by the Company or its Affiliates or by any employee benefit plan of the Company) pursuant to a transaction or a series of related
transactions which the Board of Directors does not approve; or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Merger/Sale of Assets</I>. (A)&nbsp;A merger or consolidation of the Company whether or not approved by the
Board of Directors, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting
securities of the surviving entity or the parent of such corporation) more than 50% of the total voting power represented by the voting securities of the Company or such surviving entity or parent of such corporation, as the case may be, outstanding
immediately after such merger or consolidation; or (B)&nbsp;the sale or disposition by the Company of all or substantially all of the Company&#146;s assets in a transaction requiring stockholder approval; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Change of Control&#148; shall be interpreted, if applicable, in a manner, and limited to the extent
necessary, so that it will not cause adverse tax consequences under Section&nbsp;409A. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Code</U> means the United
States Internal Revenue Code of 1986, as amended including any successor statute, regulation and guidance thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Committee</U> means
the committee of the Board of Directors to which the Board of Directors has delegated power to act under or pursuant to the provisions of the Plan, the composition of which shall at all times satisfy the provisions of Section&nbsp;162(m) of the
Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Common Stock</U> means shares of the Company&#146;s common stock, $.01 par value per share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Company</U> means Myriad Genetics, Inc., a Delaware corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Consultant</U> means any natural person who is an advisor or consultant that provides bona fide services to the Company or its Affiliates,
provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company&#146;s or its Affiliates&#146; securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Disability</U> or <U>Disabled</U> means permanent and total disability as defined in Section&nbsp;22(e)(3) of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Employee</U> means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an
officer or director of the Company or of an Affiliate), designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Exchange Act</U> means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Fair Market Value</U> of a Share of Common Stock means: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices
are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting system for the trading day on the applicable date and if such applicable date is
not a trading day, the last market trading day prior to such date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) If the Common Stock is not traded on a national securities exchange but
is traded on the over-the-counter market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in clause (1), and if bid and asked prices for the Common Stock are regularly reported, the mean between the
bid and the asked price for the Common Stock at the close of trading in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market for the trading day on which Common Stock was traded on the
applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3)
If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Participant</U> means an Employee, director or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under
the Plan.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>As used herein, &#147;Participant&#148; shall include &#147;Participant&#146;s Survivors&#148; where the context requires. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Plan</U> means this Myriad Genetics, Inc. 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Restricted Stock Grant</U> means a grant by the Company of Shares under the Plan that are subject to a lapsing forfeiture or repurchase
right. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Restricted Stock Unit Award</U> means a grant by the Company under the Plan of an unfunded, unsecured commitment by the Company
to deliver a <FONT STYLE="white-space:nowrap">pre-determined</FONT> number of Shares to a Participant at a future time in accordance with the terms and conditions of the award agreement and the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Securities Act</U> means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Shares</U> means shares of the Common Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital
stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph 3 of the Plan. The Shares issued under the Plan may be authorized and unissued shares or shares held by the Company in its treasury, or both.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Stock Right</U> means a right to Shares or the value of Shares of the Company granted pursuant to the Plan &#151; a Restricted Stock
Grant or a Restricted Stock Unit Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Survivor</U> means a deceased Participant&#146;s legal representatives and/or any person or
persons who acquired the Participant&#146;s rights to a Stock Right by will or by the laws of descent and distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PURPOSES OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is intended to encourage ownership of Shares by Employees and directors of and certain Consultants to the Company and its Affiliates
in order to attract and retain such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to promote the success of the Company or of an Affiliate. The Plan provides for the
granting of Restricted Stock Grants and Restricted Stock Unit Awards and shall not allow for the grant of stock options. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SHARES SUBJECT TO THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Commencing on December&nbsp;5, 2019, the number of Shares which may be issued from time to time pursuant to this Plan shall not exceed
1,714,267 Shares of Common Stock, plus (i)&nbsp;any Shares of Common Stock that are represented by options previously granted under the Company&#146;s 2003 Employee, Director and Consultant Stock Option Plan, as amended, and (ii)&nbsp;any Shares of
Common Stock that are represented by options or restricted stock units previously granted under the 2010 Employee, Director and Consultant Equity Incentive Plan, as amended, that are forfeited, expire or are cancelled without delivery of Shares of
Common Stock, or the equivalent of such number of Shares after the Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with
Paragraph 18 of this Plan; provided, however, that as of December&nbsp;5, 2019 no more than 5,628,833 shares shall be added to the plan pursuant to subsections (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any Restricted Stock Unit Award expires or is forfeited, cancelled, or otherwise terminated or results in any Shares not being issued
or the Company shall reacquire (at not more than its original issuance price) any Shares issued pursuant to a Restricted Stock Grant, the unissued or reacquired Shares which were subject to such Stock Right shall again be available for issuance from
time to time pursuant to this Plan. Notwithstanding the foregoing, if the Company or an Affiliate&#146;s tax withholding obligation is satisfied by withholding Shares, the number of Shares deemed to have been issued under the Plan for purposes of
the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of Shares actually issued. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ADMINISTRATION OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator of the Plan will be the Board of Directors, except to the extent the Board of Directors delegates its authority to the
Committee, in which case the Committee shall be the Administrator. Subject to the provisions of the Plan, the Administrator is authorized to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Interpret the provisions of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary or advisable
for the administration of the Plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Determine which Employees, directors and Consultants shall be granted Stock Rights; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Determine the number of Shares for which a Stock Right or Stock Rights shall be granted, provided, however, that in no event shall: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Stock Rights with respect to more than 500,000 Shares be granted to any
Participant in any fiscal year; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the aggregate grant date fair value of Shares to be granted to any <FONT
STYLE="white-space:nowrap">non-employee</FONT> director under the Plan in any calendar year may not exceed $500,000; provided however that the foregoing limitation shall not apply to Stock Rights made pursuant to an election to receive equity in
lieu of cash for all or a portion of fees received for service on the Board of Directors or any Committee thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Specify the terms
and conditions upon which a Stock Right or Stock Rights may be granted; provided, however, that except in the case of death, disability or Change of Control or as otherwise provided in an employment or other agreement between the Participant and the
Company, Stock Rights shall not vest, and any right of the Company to restrict or require Shares subject to a Stock Grant shall not lapse, less than one year from the date of grant and no dividends or dividend equivalents shall be paid on any Stock
Right prior to the vesting of the underlying Shares; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Amend any term or condition of any outstanding Stock Right, provided that no such
change shall impair the rights of a Participant under any grant previously made without such Participant&#146;s consent; provided however, except as otherwise provided in an employment or other agreement between the Participant and the Company, the
Administrator is not authorized to accelerate the vesting schedule of an outstanding Stock Right except in the case of death, disability or Change of Control; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Adopt any <FONT STYLE="white-space:nowrap">sub-plans</FONT> applicable to residents of any specified jurisdiction as it deems necessary or
appropriate in order to comply with or take advantage of any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration of the Plan, which
<FONT STYLE="white-space:nowrap">sub-plans</FONT> may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock Right; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in the context of potential tax
consequences under Section&nbsp;409A of the Code. Subject to the foregoing, the interpretation and construction by the Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise determined by
the Board of Directors, if the Administrator is the Committee. In addition, if the Administrator is the Committee, the Board of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent permitted under applicable law, the Board of Directors or the Committee may allocate all or any portion of its responsibilities
and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. The Board of Directors or the Committee may revoke any such allocation or delegation at any time.
Notwithstanding the foregoing, only the Board of Directors or the Committee shall be authorized to grant a Stock Right to any director of the Company or to any &#147;officer&#148; of the Company (as defined by Rule
<FONT STYLE="white-space:nowrap">16a-1</FONT> under the Exchange Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ELIGIBILITY FOR PARTICIPATION.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator will, in its sole discretion, name the Participants in the Plan; provided, however, that each Participant must be an
Employee, director or Consultant of the Company or of an Affiliate at the time a Stock Right is granted. Notwithstanding the foregoing, the Administrator may authorize the grant of a Stock Right to a person not then an Employee, director or
Consultant of the Company or of an Affiliate; provided, however, that the actual grant of such Stock Right shall be conditioned upon such person becoming eligible to become a Participant at or prior to the time of the execution of the Agreement
evidencing such Stock Right. The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant of Stock Rights or any grant under any other benefit plan
established by the Company or any Affiliate for Employees, directors or Consultants. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMS AND CONDITIONS OF RESTRICTED STOCK GRANTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Restricted Stock Grant to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the extent
required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of
the Company, subject to the following minimum standards: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Agreement shall state the purchase price per share, if any, of the
Shares covered by each Restricted Stock Grant, which purchase price shall be determined by the Administrator but shall not be less than the minimum consideration required by the<B> </B>Delaware General Corporation Law, if any, on the date of grant
of the Restricted Stock Grant; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Agreement shall state the number of Shares to which the Restricted Stock Grant pertains; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Agreement shall include the terms of any right of the Company to restrict or reacquire the Shares subject to the Restricted Stock
Grant, including the time and events upon which such rights shall accrue and the purchase price therefor, if any within the parameters set forth in the Plan; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Dividends (other than stock dividends to be issued pursuant to Section&nbsp;18 of the Plan) may accrue but shall not be paid prior to the
time, and only to the extent that, the restrictions or rights to reacquire the Shares subject to the Restricted Stock Grant lapse. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARDS. </U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Restricted Stock Unit Award to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the
extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best
interest of the Company. Each Agreement shall include the terms of any right of the Company including the right to terminate the Restricted Stock Unit Award without the issuance of Shares, the terms of any vesting conditions within the parameters
set forth in the Plan, or events upon which Shares shall be issued provided that dividends (other than stock dividends to be issued pursuant to Section&nbsp;18 of the Plan) or dividend equivalents may accrue but shall not be paid prior to and only
to the extent that, the Shares subject to the Restricted Stock Unit Award vest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends that the Plan and any Restricted Stock Unit Awards granted hereunder be
exempt from the application of Section&nbsp;409A of the Code or meet the requirements of paragraphs (2), (3) and (4)&nbsp;of subsection (a)&nbsp;of Section&nbsp;409A of the Code, to the extent applicable, and be operated in accordance with
Section&nbsp;409A so that any compensation deferred under any Restricted Stock Unit Award (and applicable investment earnings) shall not be included in income under Section&nbsp;409A of the Code. Any ambiguities in the Plan shall be construed to
effect the intent as described in this Paragraph 7. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PAYMENT IN CONNECTION WITH THE ISSUANCE OF RESTRICTED STOCK GRANTS AND ISSUE OF SHARES FOR STOCK RIGHTS.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Restricted Stock Grant requiring payment of a purchase price for the Shares as to which such Restricted Stock Grant
is being granted shall be made (a)&nbsp;in United States dollars in cash or by check, or (b)&nbsp;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six months (if required to avoid negative
accounting treatment) and having a Fair Market Value equal as of the date of payment to the purchase price of the Restricted Stock Grant, or (c)&nbsp;at the discretion of the Administrator, by any combination of (a)&nbsp;and (b) above; or
(d)&nbsp;at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company shall when required by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Right was made to the Participant (or to the Participant&#146;s Survivors, as the case may be), subject to any escrow provision
set forth in the applicable Agreement. In determining what constitutes &#147;reasonably promptly,&#148; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or
regulation (including, without limitation, state securities or &#147;blue sky&#148; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>RIGHTS AS A SHAREHOLDER.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Participant to whom a Stock Right has been granted shall have rights as a shareholder with respect to any Shares covered by such Stock
Right, except after issuance of Shares as set forth in any Agreement and tender of the aggregate purchase price, if any, for the Shares being purchased, and registration of the Shares in the Company&#146;s share register in the name of the
Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By its terms, a Stock Right granted to a Participant shall not be transferable by the Participant other than (i)&nbsp;by will or by the laws of
descent and distribution, or (ii)&nbsp;as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no Stock Right may be transferred by a Participant for value. The designation of a beneficiary of a
Stock Right by a Participant, with the prior approval of the Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except as provided above during the Participant&#146;s
lifetime, a Stock Right shall only be exercisable by or issued to such Participant (or his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject
to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment
or similar process upon a Stock Right, shall be null and void. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an
Affiliate for any reason before the Participant has accepted a Restricted Stock Grant or a Restricted Stock Unit Award and paid the purchase price, if required, such grant shall terminate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Paragraph 11 and Paragraph 12 below, a Participant to whom a Stock Right has been issued under the Plan who is absent from
work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be
deemed, by virtue of such absence alone, to have terminated such Participant&#146;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, for purposes of this Paragraph 11 and Paragraph 12 below, any change of employment or other service within or among the Company
and any Affiliates shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE OTHER THAN FOR
CAUSE OR DEATH OR DISABILITY.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, in the event of a
termination of service for any reason (whether as an Employee, director or Consultant), other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 13, 14, and 15, below, before all forfeiture
provisions or Company rights of repurchase shall have lapsed, then the Company shall have the right to cancel or repurchase that number of Shares subject to a Restricted Stock Grant as to which the Company&#146;s forfeiture or repurchase rights have
not lapsed or cancel a Restricted Stock Unit Award without the issuance of any additional Shares thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE FOR CAUSE.</U>
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply if the Participant&#146;s
service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) All Shares subject
to any Restricted Stock Grant that remain subject to forfeiture provisions or as to which the Company shall have a repurchase right and Restricted Stock Unit Awards for which Shares have not been issued shall be immediately forfeited to the Company
as of the time the Participant is notified his or her service is terminated for Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Cause is not limited to events which have
occurred prior to a Participant&#146;s termination of service, nor is it necessary that the Administrator&#146;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#146;s termination of service,
that either prior or subsequent to the Participant&#146;s termination the Participant engaged in conduct which would constitute Cause, then all Shares subject to any Restricted Stock Grant that remained subject to forfeiture provisions or as to
which the Company had a repurchase right and Restricted Stock Unit Awards for which Shares have not been issued on the date of termination shall be immediately forfeited to the Company. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF TERMINATION OF SERVICE FOR
DISABILITY.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply if a
Participant ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability: to the extent the forfeiture provisions or the Company&#146;s rights of repurchase have not lapsed on the date of the
Participant&#146;s termination due to Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro
rata portion of the Shares subject to such Stock Right through the date of the Participant&#146;s termination due to Disability as would have lapsed had the Participant not been terminated due to Disability. The proration shall be based upon the
number of days accrued prior to the date of the Participant&#146;s termination due to Disability. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall make the
determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used
for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EFFECT ON RESTRICTED STOCK GRANTS AND RESTRICTED STOCK UNIT AWARDS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR
CONSULTANT.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in a Participant&#146;s Agreement, the following rules apply in the event
of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate: to the extent the forfeiture provisions or the Company&#146;s rights of repurchase have not lapsed on the date of death,
they shall lapse in full on the Participant&#146;s date of death. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>PURCHASE FOR INVESTMENT.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the offering and sale of the Shares shall have been effectively registered under the Securities Act, the Company shall be under no
obligation to issue the Shares under the Plan unless and until the following conditions have been fulfilled: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The person who receives a
Stock Right shall warrant to the Company, prior to the receipt of such Shares, that such person is acquiring such Shares for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such
Shares, in which event the person acquiring such Shares shall be bound by the provisions of the following legend (or a legend in substantially similar form) which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such
Stock Right: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise
transferred by any person, including a pledgee, unless (1)&nbsp;either (a) a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&nbsp;the Company shall have received an opinion
of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2)&nbsp;there shall have been compliance with all applicable state securities laws.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) At the discretion of the Administrator, the Company shall have received an opinion of its counsel that the Shares may be issued in
compliance with the Securities Act without registration thereunder. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>DISSOLUTION OR LIQUIDATION OF THE COMPANY.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the rights of a Participant or a Participant&#146;s Survivors have not otherwise terminated and expired, the Participant or the
Participant&#146;s Survivors will have the right immediately prior to such dissolution or liquidation to accept any Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such
dissolution or liquidation. Upon the dissolution or liquidation of the Company, all Restricted Stock Grants and Restricted Stock Unit Awards which have not been accepted, to the extent required under the applicable Agreement, will terminate and
become null and void and any outstanding Restricted Stock Unit Awards shall immediately terminate unless otherwise determined by the Administrator or specifically provided in the applicable Agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ADJUSTMENTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the occurrence of any of the following events, a Participant&#146;s rights with respect to any Stock Right granted to him or her hereunder
shall be adjusted as hereinafter provided, unless otherwise specifically provided in a Participant&#146;s Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Stock Dividends and Stock Splits</U>. If (i)&nbsp;the shares of Common Stock shall be
subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii)&nbsp;additional shares or new or different shares or other
securities of the Company or other <FONT STYLE="white-space:nowrap">non-cash</FONT> assets are distributed with respect to such shares of Common Stock, each Stock Right and the number of shares of Common Stock deliverable thereunder shall be
appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the purchase price per share, to reflect such events. The number of Shares subject to the limitations in Paragraph 3(a) and 4(c)<B>
</B>shall also be proportionately adjusted upon the occurrence of such events. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Corporate Transactions</U>. If the Company is to be
consolidated with or acquired by another entity in a merger, consolidation, or sale of all or substantially all of the Company&#146;s assets other than a transaction to merely change the state of incorporation (a &#147;Corporate Transaction&#148;),
the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#147;Successor Board&#148;), shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) as to outstanding Restricted Stock Unit Awards, either (a)&nbsp;make appropriate provision for the continuation of such
Restricted Stock Unit Awards by substituting on an equitable basis for the Shares then subject to such Restricted Stock Unit Awards either the consideration payable with respect to the outstanding shares of Common Stock in connection with the
Corporate Transaction or securities of any successor or acquiring entity; or (b)&nbsp;terminate such Restricted Stock Unit Awards in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction
to a holder of the number of shares of Common Stock which would have been issued pursuant to such Restricted Stock Unit Award. For purposes of determining the payments to be made in the case of a Corporate Transaction the consideration for which, in
whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) as to outstanding Restricted Stock Grants either, (a)&nbsp;make appropriate provision for the continuation of such
Restricted Stock Grants on the same terms and conditions by substituting on an equitable basis for the Shares then subject to such Restricted Stock Grants either the consideration payable with respect to the outstanding Shares of Common Stock in
connection with the Corporate Transaction or securities of any successor or acquiring entity; or (b)&nbsp;terminate such Restricted Stock Grants in exchange for payment of an amount equal to the consideration payable upon consummation of such
Corporate Transaction to a holder of the number of shares of Common Stock comprising such Restricted Stock Grant; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
taking any of the actions permitted under this Paragraph 18(b), the Administrator shall not be obligated by the Plan to treat all Stock Rights, all Stock Rights held by a Participant, or all Stock Rights of the same type, identically. The
Administrator or the Successor Board shall determine the specific adjustments to be made under this Paragraph 18, including, but not limited to the effect of any, Corporate Transaction or Change of Control and, subject to Paragraph 4, its
determination shall be conclusive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Recapitalization or Reorganization</U>. In the event of a recapitalization or
reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant shall be entitled to receive
after the recapitalization or reorganization for the price paid, if any, the number of replacement securities which would have been received if such Shares had been issued prior to such recapitalization or reorganization. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>ISSUANCES OF SECURITIES.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock
of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights. Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in
property (including without limitation, securities) of the Company prior to any issuance of Shares pursuant to a Stock Right. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>FRACTIONAL SHARES.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares shall be issued under the Plan and the Participant shall receive from the Company cash in lieu of such fractional shares
equal to the Fair Market Value thereof. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>WITHHOLDING.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act withholdings or other
amounts are required by applicable law or governmental regulation to be withheld from the Participant&#146;s salary, wages or other remuneration in connection with the issuance of a Stock Right or Shares under the Plan or for any other reason
required by law, the Company may withhold from the Participant&#146;s compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the
statutory minimum amount of such withholdings unless a different withholding arrangement, including the use of shares of the Company&#146;s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law). For purposes
hereof, the fair market value of the shares withheld for purposes of payroll withholding shall be determined in the manner set forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date. If
the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the difference in cash to the Company or the Affiliate employer. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>TERMINATION OF THE PLAN.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan will terminate on September&nbsp;14, 2027, the date which is ten years from the <U>earlier</U> of the date of its adoption by the
Board of Directors and the date of its approval by the shareholders of the Company. The Plan may be terminated at an earlier date by vote of the shareholders or the Board of Directors of the Company; provided, however, that any such earlier
termination shall not affect any Agreements executed prior to the effective date of such termination. Termination of the Plan shall not affect any Stock Rights theretofore granted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>AMENDMENT OF THE PLAN AND AGREEMENTS.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan may be amended by the shareholders of the Company. The Plan may also be amended by the Administrator; provided that any amendment
approved by the Administrator which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval. Any modification or amendment of the Plan shall not, without the consent of a
Participant, adversely affect his or her rights under a Stock Right previously granted to him or her. With the consent of the Participant affected, the Administrator may amend outstanding Agreements in a manner which may be adverse to the
Participant but which is not inconsistent with the Plan. In the discretion of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>EMPLOYMENT OR OTHER RELATIONSHIP.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing in this Plan or any Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment, consultancy or
director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant a right to be retained in employment or other service by the Company or any
Affiliate for any period of time. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>SECTION 409A.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a Participant is a &#147;specified employee&#148; as defined in Section&nbsp;409A of the Code (and as applied according to procedures of the
Company and its Affiliates) as of his separation from service, to the extent any payment under this Plan or pursuant to the grant of a Restricted Stock Unit Award constitutes deferred compensation (after taking into account any applicable exemptions
from Section&nbsp;409A of the Code), and to the extent required by Section&nbsp;409A of the Code, no payments due under this Plan or pursuant to a Restricted Stock Unit Award may be made until the earlier of: (i)&nbsp;the first day of the seventh
month following the Participant&#146;s separation from service, or (ii)&nbsp;the Participant&#146;s date of death; provided, however, that any payments delayed during this <FONT STYLE="white-space:nowrap">six-month</FONT> period shall be paid in the
aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant&#146;s separation from service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Administrator shall administer the Plan with a view toward ensuring that Stock Rights under the Plan that are subject to Section&nbsp;409A
of the Code comply with the requirements thereof, but neither the Administrator nor any member of the Board, nor the Company nor any of its Affiliates, nor any other person acting hereunder on behalf of the Company, the Administrator or the Board
shall be liable to a Participant or any Survivor by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to a Stock Right, whether by reason of a failure to satisfy the requirements of
Section&nbsp;409A of the Code or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>INDEMNITY.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither the Board nor the Administrator, nor any members of either, nor any employees of the Company or any parent, subsidiary, or other
Affiliate, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities with respect to this Plan, and the Company hereby agrees to indemnify the members of the
Board, the members of the Committee, and the employees of the Company and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable counsel fees) arising from any such act, omission, interpretation,
construction or determination to the full extent permitted by law. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>CLAWBACK.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any
Stock Right (whether or not settled) or cause a Participant to forfeit any Stock Right (whether or not vested) in the event that the Company&#146;s Clawback Policy then in effect is triggered. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>GOVERNING LAW.</U> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Plan shall be construed and enforced in accordance with the law of the State of Delaware. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>d102302dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">


<IMG SRC="g102302g1015052938193.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">News Release</TD></TR>
</TABLE> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Media Contact: Jared Maxwell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Investor Contact: Scott Gleason&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:6.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;(801) <FONT STYLE="white-space:nowrap">505-5027</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:8.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(801) <FONT STYLE="white-space:nowrap">584-1143</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:6.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;jmaxwell@myriad.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">sgleason@myriad.com</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Myriad Genetics Files Fiscal Year 2020 Proxy Statement, Implements Corporate </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Governance Changes In Support of Stakeholder Interests </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SALT LAKE CITY, Oct. 15</B><B>, </B><B>2020 </B>&#150; Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision
medicine, announced today that the company has filed its fiscal year 2020 proxy statement and made significant changes to its board structure, executive compensation and corporate governance policies to better serve key company stakeholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Myriad has executed a significant effort during my time as Chair to improve corporate governance to reflect shareholder interests while
continuing our mission to improve and transform lives,&#148; said S. Louise Phanstiel, chair of the Board of Directors, Myriad Genetics. &#147;By the end of this year, <FONT STYLE="white-space:nowrap">two-thirds</FONT> of our board will consist of
new members who bring deep healthcare and technology expertise spanning payer markets, product development, information technology, and business management. By intensifying our focus on corporate governance and transparency, Myriad is now positioned
to advance its leadership in the healthcare industry.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Membership </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since the fall of 2019, Myriad has added six new members to its board of directors and announced the retirement of three board members. New
board members include Lee N. Newcomer M.D., Colleen F. Reitan, Daniel M. Skovronsky M.D., Ph.D, Daniel K. Spiegelman, Rashmi Kumar, and Paul J. Diaz. Retiring from the board of directors following the annual meeting on December&nbsp;4, 2020 are John
T. Henderson, M.D., Lawrence C. Best, and Walter Gilbert, Ph.D. In March 2020, S. Louise Phanstiel assumed the role of board chair. The new board structure is designed to combine the continuity of tenured directors with new perspectives from
recently added members with broad experience in managed care, health technology, and financial oversight. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Myriad is enacting new policies that reflect industry best practices, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Moving from plurality voting to majority voting for directors </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Implementing a retirement process for directors at age 75 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Expanding the scope of the Audit and Finance Committee and redefining the Strategic Committee to the new Research
and Product Innovation Committee </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Enhancing board diversity with 44% of board members now reflecting diverse backgrounds </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Executive Compensation Changes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Myriad also is making multiple changes to its compensation policies to match business performance with compensation. These changes include:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Business objectives for Vice Presidents and above will now be based on company financial performance, with 70% of
bonus payout tied to the achievement of revenue and operating income targets </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Equity granted as long-term incentive compensation will now consist of 50% performance shares, with the number of
shares tied to the company&#146;s performance on earnings per share and relative total shareholder return </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reducing management payouts under a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-of-control</FONT></FONT> and moving to a double trigger system for equity vesting </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Elimination of future cash long-term incentive programs </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Change in Fiscal Year End </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to
better align with general industry standards for financial reporting and facilitate comparison with other companies, Myriad will adjust its fiscal year end from June 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to December 31<SUP
STYLE="font-size:85%; vertical-align:top">st</SUP>. Myriad will file an Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-KT</FONT> for a <FONT STYLE="white-space:nowrap">six-month</FONT> transition period from July&nbsp;1, 2020 through
December&nbsp;31, 2020. Fiscal year 2021 will now run from January&nbsp;1, 2021 through the end of the calendar year on December&nbsp;31, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;As we take decisive actions to enhance governance and drive sustainable, profitable growth, we remain focused on our purpose-driven
mission to improve and transform lives by unlocking the power of genetics,&#148; Paul J. Diaz, president and CEO of Myriad Genetics.&nbsp;&#147;We will continue to transform our business by listening and responding to the needs of our stakeholders,
creating new commercial capaibilties, and delivering new levels of value, innovation and service excellence.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Myriad Genetics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Myriad Genetics, Inc. is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering
molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major
medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. For more information, visit the Company&#146;s website: www.myriad.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Myriad, the Myriad logo, BART, BRAC<I>Analysis</I>, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice,
myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and
foreign countries. <FONT STYLE="white-space:nowrap">MYGN-F,</FONT> <FONT STYLE="white-space:nowrap">MYGN-G.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This press release contains &#147;forward-looking statements&#148; within the meaning of the Private Securities Litigation Reform Act of 1995,
including statements related to <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the Company&#146;s board consisting of new members by the end of the year; the Company advancing its leadership in the healthcare industry; retirement from the
board of directors following the annual meeting on December&nbsp;4, 2020 of John T. Henderson, M.D., Lawrence C. Best, and Walter Gilbert, Ph.D; the planned new policies and governance changes listed above; the Company adjusting its fiscal year end
from June 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> to Dec. 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>; the Company continuing to transform its business; the Company delivering new levels of value, innovation and
service excellence; and the Company&#146;s strategic directives under the caption &#147;About Myriad Genetics.&#148;&nbsp;These &#147;forward-looking statements&#148; are based on management&#146;s current expectations of future events and are
subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to:
uncertainties associated with <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including its possible effects on our operations and the demand for our products and services; our ability to efficiently and flexibly manage our business amid
uncertainties related to <FONT STYLE="white-space:nowrap">COVID-19;</FONT> the risk that sales and profit margins of our molecular diagnostic tests and pharmaceutical and clinical services may decline; risks related to our ability to transition from
our existing product portfolio to our new tests, including unexpected costs and delays; risks related to decisions or changes in governmental or private insurers&#146; reimbursement levels for our tests or our ability to obtain reimbursement for our
new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely
manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that
licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services and any future tests and services are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems
with operating our laboratory testing facilities and our healthcare clinic; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and
foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms,
if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; risks related to our projections about our business, results of operations and financial condition;
risks related to the potential market opportunity for our products and services; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of
patent-infringement claims or challenges to the validity of our patents or other intellectual property; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and
patents or enforcement in the United States and foreign countries, such as the Supreme Court decisions in <I>Mayo Collab. Servs. v. Prometheus Labs., Inc.</I>, 566 U.S. 66 (2012), <I>Ass&#146;n for Molecular Pathology v. Myriad Genetics, Inc.</I>,
569 U.S. 576 (2013), and <I>Alice Corp. v. CLS Bank Int&#146;l</I>, 573 U.S. 208 (2014); risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with
financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading &#147;Risk Factors&#148;
contained in Item 1A of our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended June&nbsp;30, 2020, which has been filed with the Securities and Exchange Commission, as well as any updates to
those risk factors filed from time to time in our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> All information in this press release is as of the date
of the release, and Myriad undertakes no duty to update this information unless required by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mygn-20201009.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/15/2020 3:12:54 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:mygn="http://imetrix.edgar-online.com/20201009"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://imetrix.edgar-online.com/20201009"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201009_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mygn-20201009_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>mygn-20201009_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/15/2020 3:12:54 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>mygn-20201009_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-5 Build:20200707.2 -->
<!-- Creation date: 10/15/2020 3:12:54 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="mygn-20201009.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g102302g1015052938193.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g102302g1015052938193.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 ,8# 2(  A$! Q$!_\0
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M.JMCKUX-=!HGP]_X2JU77/%-Y=375V/,2)'VK&AY _+M2_&T Z5I7_7RP_\
M':]-LE"6-NJC"B-0!^%.=67LXR6[ZBA2BZDHO9=/4\5\3^'YOAEJUCK.B74Y
MM))-DD<C9YZ[3CJ",_E7J>MZ=%XH\)SVPZ74 :,GLV,J?SQ7)_&D?\4E:_\
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)P'2BBBI&?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>d102302d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mygn-20201009.xsd" xlink:type="simple"/>
    <context id="duration_2020-10-09_to_2020-10-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000899923</identifier>
        </entity>
        <period>
            <startDate>2020-10-09</startDate>
            <endDate>2020-10-09</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-10-09_to_2020-10-09"
      id="Hidden_dei_EntityRegistrantName">MYRIAD GENETICS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-10-09_to_2020-10-09">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-10-09_to_2020-10-09"
      id="Hidden_dei_EntityCentralIndexKey">0000899923</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2020-10-09_to_2020-10-09"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2020-10-09_to_2020-10-09">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2020-10-09_to_2020-10-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-10-09_to_2020-10-09">2020-10-09</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-10-09_to_2020-10-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-10-09_to_2020-10-09">0-26642</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-10-09_to_2020-10-09">87-0494517</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-10-09_to_2020-10-09">320 Wakara Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-10-09_to_2020-10-09">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-10-09_to_2020-10-09">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-10-09_to_2020-10-09">84108</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-10-09_to_2020-10-09">(801)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-10-09_to_2020-10-09">584-3600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-10-09_to_2020-10-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-10-09_to_2020-10-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-10-09_to_2020-10-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-10-09_to_2020-10-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-10-09_to_2020-10-09">Public Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-10-09_to_2020-10-09">MYGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-10-09_to_2020-10-09">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-10-09_to_2020-10-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140284827178232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MYRIAD GENETICS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000899923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  09,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-26642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0494517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">320 Wakara Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-3600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Public Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MYGN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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M BHL""H+.P^^=I)*TM W.Y4QV:^W.YW;N RH#Z(ODSJGJD^=OD[6XR3AJ0-
M,BJI^YQVB/8M8WW5@>+]*V-!^TQCG.+HH6M9;QWPN@^#E&3IZ73/%!>:%ID>
MU(/"GE1FT)C3$V5%UAB],Z]I)'PI5T N7.;T Y>B=&*NY4K(*=)I("HCC2/H
MK4!.D\#TSS&=1!1<+CI*:.,"R6*'^%LNY3\E5M1[**3<#*8T$D5F.2(X_>#!
M7#R3+U)DB<^3]0Y;QZ<DO:/[@/GCFY3&U>"V-@E=J2*3T 0[3K1=^**Q+"01
MC?)!+7AK-)\]K".6P,M6(.53V,*OS97VV)"X%Q_KL TD3'4-O:$EC#(1!/VC
M6M0^R-[]D2RQXF+P_>!GHV?\;3 (CPX:,<YX;+;^M]23V^K<6CF]DZ+5"N+<
M?[EAD?%U'.F,$\^^6S@IE2? 47(!AZ(Z,M\=MV<8<3U-8W/;<_H?>OZ[Z]R"
M!L?ET;0_^O_R*O^.8[;<GL,5O;J@&TO"0YC3+^%]E;L'4@Y"HM +ZD1=@WYQ
M3[T\\M(_X%?ZOKZ&A@\2SULRIWO\&6HQJ#=;U6-8EZ5JCS^%]RBYGQON_Q+%
M#U!+ P04    " !;.D]1EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y
M;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI
M0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:W
MO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:
M>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%B
MM/XU@LD/['X 4$L#!!0    ( %LZ3U$<.&7J/P$  #P"   /    >&PO=V]R
M:V)O;VLN>&ULC5'+;L) #/R5U7Y $U"+5$2XE#Z0JA:5BON2=8C%/B*O RU?
M7R=15*1>>O)Z;(UG9A?G2,=]C$?UY5U(A:Z9FWF6I;(&;])-;"#(I(KD#4M+
MARPU!,:F&H"]RZ9Y/LN\P:"7BY%K0]EU$QE*QA@$[( =PCG]SKM6G3#A'AWR
M=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\Q,#&;4N*SA5Z,@QV0(SE'WC;B?PT^]0C
M;/8?1H04>I8+8864N-_H^8UH/($L#UW+\0D= ZT,PS/%ML%PZ&C$179EH\]A
MK$.(<_I/C+&JL(15+%L/@8<<"5PG,*0:FZ15,!X*/:XH$ZQZ#"PAJ748J&2W
M<RJGUW9PS2+W*D.:HPQH;0?AHUH+%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N
M0;#W\!J-'<V/'[?\ 5!+ P04    " !;.D]1)!Z;HJT   #X 0  &@   'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K
M+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;
MM(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /
M,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G
M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 6SI/4660>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( %LZ3U'HT)>J\    "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %LZ3U&97)PC$ 8
M )PG   3              "  <X!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 6SI/481=ME-4!   UQ   !@              ("!#P@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %LZ3U&#J:4#U $
M #(&   -              "  9D,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  !P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d102302d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d102302d8k.htm">d102302d8k.htm</File>
    <File>d102302dex101.htm</File>
    <File>d102302dex102.htm</File>
    <File>d102302dex31.htm</File>
    <File>d102302dex991.htm</File>
    <File>mygn-20201009.xsd</File>
    <File>mygn-20201009_lab.xml</File>
    <File>mygn-20201009_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d102302d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d102302d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mygn-20201009_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mygn-20201009_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mygn-20201009.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mygn",
   "nsuri": "http://imetrix.edgar-online.com/20201009",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d102302d8k.htm",
      "contextRef": "duration_2020-10-09_to_2020-10-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d102302d8k.htm",
      "contextRef": "duration_2020-10-09_to_2020-10-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://imetrix.edgar-online.com//20201009/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-20-269801-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-269801-xbrl.zip
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M@9Y'W'7C9SN77:NC/(^/M&C&'Y;32(J@T 0SV*C7:M];W#5K%LQF+?;,$+#
M_'&S#M_AT??HJX?NS-L'$832X9[%KEEP;DL[3F.#<6*8\[O,#@C_6-B#N,F(
M]T6Y&PC^%2/'X*XW^8,""ED;<77:NNR\+$5-+$-.32(D-K,6H F ,"UI9KD7
M7B]29$;R='Q'!:#U2&'=A:"*6BKRPV#24NZ3U!J*/ P\A&(4J ><%O7:I?#X
M&%3<O"XCV;8^&<0T/]?^%7#X47H"WH&^WCS>6&Z\>7/4^%.AXYX_=FSXRJ'U
M;XF;D[?EVM'IT7'][3+T/ =OGNR(-;?5TCOQ:XO$S>@M*##2 _8;V.C:E>1&
M;&1"U)\!.+ :9%KR'!A-^#KD_KK;U%+#H=3ZC[ K*,B8X=:_\(9T;N]8>SCR
MU$0$K[XE64G*KE1ENC,D^N ?-/B>X&'OQ"58H1,N7#<06ML_G\$HKV^L#PX;
M-?8S_\H##G\F*[SA5_"*UD-!"SY>!_=J[&^,@#ONA>PS_RH8#C*+@-+BF$4&
M %(+U\$-6&624N^[MO%^"OE@_51R!K8;!:-Y_R='VUB?YR=']=K)+NEB-_+$
MK@T]Y5$ *)<C[C'Q*)PHE _H0 -W"WW BK!NA@M?$ME[,7Z>1B3^\=U)H_[V
M3(,D]\1HH'S!?%(1)53A7H0N)0.3GL-V@:FU>*>1:"^@W59[6SRIU0_FJ2IM
MJ(X',A1E='H%-!H'?+2$)S\KT#DWN)HMK=/CDZ/RX9M:3E3.VJ:OOH57*F07
MHY$'N@,4Q.OSP4<0'&"'FJA10'($'KGA#B"F'C.Q8[ =4# QC^LX)+N/'3U/
MVF05G17.6P/A?*4H/Q^!D <!ADY%5SVRKO#4&'<-7^+>LI/RCZPG/90'4H-P
M"(7OPFZ&"C9T&'DA]X6*M#=A&IA+]R;4TW907<"#L7%L5B$558Q@'* 4?Q*_
MZRD/)L=^J'@D&L^:%>?=5OK<E*!3I%,XUT(PRYZ?A"\"$,,='Z:(3&KEHM*H
MF%4=-!?2VYNM(W*[BKC5I[4*S5HJ]C8?XYN) :[G)<\ZOF:"H^_/<@,%B\3K
MSX$,8?O1MXE\:[SJ)YL:7:6\+H>M#X$ $<NG;X^.SN8E\"JO9=;)8-D=94\6
MSS/E*X5SBP] 0!HA;)3*\-U&0"1'C6-+[3.)-<RG%>MO6>OC+6L<UBK0<+4C
ML"?;#<GV#B2U PCW^U] S(&L\_["-#M%!@QML#%/L/4C7JXW4C2;R0 G%'M4
MJYB6>Z+=.='>! +E+)8T4J4*:MW@NM?;W*C]$Q$O(*7LI+"R4O+6C]QRH]@]
M6(^43=L],3\W,7>TCD2P)^GM2/I0E(^*SGHD;=N^>'01],S4RC$VOPC :QCE
M%3\1@UH? %:PV$S?9\[_O)GS;;)S:_CE"U:;$U1ZU83 /1YA,K5KSH Y'M?Z
MI5(UVR+QE1,Z]P%'YGWU5,[=9 BOBOK%4FO?Z'Y=V;(R(G!A%=:K[QZH'Y %
M -%41V55Y9^M/LBJY4F]T269LW&$_";J@@/)T)P#Y-V%ROE:8O]3J]3J;,0#
M]L"]Z,]2!V1%C.'P+8YB?KKZDR B)IK8SMSF:.J<R8XR($XN7G'M\M_9)T^!
M$0^&H0>F(?O"@Z\B7%DE]!+&;,=WT2 7K#MA#L7.8<2O(#H$%>',!+:E9H!F
ML.9QTC[K!VH<#M"N'V&PFVOFBI[T32FMB0_6CME\U?VTV/Z0%9$0WIX9<J!(
M8=Q%4BGN"$MQ,?]B7(1&M]S(&3&OCG]F:'0:IKU3@U>>-_=5.&_GX\O 9?E@
M>;HY'N$3#= R_5_,M7Q>['1Z2V@*<[:Y!"KGDBX#(#]B+R _7Y$?%FE!K0!'
M-K6#]P5(\LW,,5'$"<WE37#RL82ID91]@ _>!.)!:N@'1,U]!P.*W'&PWA0;
MXU4 +@]<;9(Z[B(G\+#($R<P3:>5- $DR%_D(*YS)'2-(Y_?\-E2DSRT*<2_
M_PV41BY1BN$<3>)7*0.G*V#7P<#QQGRB"^:  MZ_D!A#X!NKH/G=*?UW%B]H
M])@)0E7I6@6"8WF&=K=GAF'2V4C;A^O;R_9MN77]^?/%S5V[&7_X8T?:ZO7<
M4!NCCT!+%$-:H=<[H1@: CFNU!HY-DAZL-<*C"VSULTJ+P48F&$4D!MQ*0.0
M'"K0*(!: "L'97I-13>!/F-MS\J5=-,S+)Q0T@\IS@9OYONATA"^YM!\PBZ"
M *40MM9YS2MLD[#:FUVH@:(X6)4/-SM])V #\1(6$-0N:QEQ"K#CC2B!\MA%
M/Q"TLM7GCW8"^#6@+>?T6XE]F022NPQ3]T!ONF1>=WRG@I;)2:-1.S--Z*%^
MAON-.L*^:\56 KT\8-Q5(]1MG)03ZG+<N5@)I0JT H%WP2")\!@5K)@:>&T$
M)E.CDIPM $/ZM"8B;)J*@%8'4O1 P\7M+#&5P)A4H(AYFN9(T08"SUZ1LM09
MF)P$)L?"9-5G*[8T@55L(8XQ-M&>$U0#2\N=+IPFBH"@[\E@7'/E6,;C<0<U
M.IH *M++\6L7=&M5^H=@ CBYE?V^[@I12N'D?P$C[ ;@I@LS+!B(MH^)A9&@
M#7$Z+<";FB J;H"]:5XT%]V\'?I!!(&U,^\J[#,,,.A&P<22XLV@<EDI60#N
M'&DK=Z<0X 17$K2A@+Y8=1:64L##GE@2_UD!$I*ZNW\)[H6#$KOV48_V)S1,
M!W6A3Q8J]RI+>-(<H'TJ4^)NPX1#/?45UMUZI*UT+1 ):MJ,%20P!*.".1[0
MNC<Q^X+$PTV]T)!</OB&@_1V!)8;T9A@WD9@P$X,L@'2"7,E)HY8+U##F ;4
MRLF[.,)08662Y4J853=G$;W#_-ZW:74<?[\D]&"S 6O8)20:WRP>(]^VR9GY
M60V4-?=@SAX!F0/HU$BWR#MJ[(,P&<@1/ 'W#\"& 2+\/9*8]T+=P',D-G#.
M<>W[L]6&Q)XD]R2YFB2-0B:W&_[Q1#D$KZB/598.; 6(=C2-'H0FSQS(,(\D
M22:[*NJFNL==B@#I(+<7R650)=)H+](/OAK/<$ .%&3)<#U(&3==L 5[,M0'
M>[[8\\6.^,*-B"WF"7=*=B,^,58"V10HQ,$ZHIDT]WA@++2N\L',!;&-)R;R
MW^ZI=D^UNZ5:\%L0D$0PSI#JX1M&-\T07=8;]N&,*')/BGM2W(FM"\+24F..
MQ"PNEH8']!&M@' R-0#01"B&8\7P:B1R/ZT]<,"B$9H/&6,"31(5A7%HQN&1
M%JEP$)H6]E5?*;2ZN59^W" <<$K)8;;#R'W?Q@9-'F->)VP6U]N-*_Y34LRW
MG4->BG,]J?B.,CFCV8 '(B/&KG!7(3<>=FX4C>%8&,$*(1OD6+X71:K^R&9
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MU3Y'M3^RODHPGG[+@G%Z7I5^G\,$8DS BAAG0TW;>.[K#W=#<&O<?XC<9>]
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MJJOLML*R5VJ^^"]9?/-"Y[F&S=F:_;:\_K"+;IPM+;IN-M?#S/%"WE6[RIW
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M'J4E+ >?H - Z0(OI/2N_@"3 9=8K4K@'<Q9A1@<#S&"R <(4H-E2Y>+,EK
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MM:6GW'/<E2HOZMZY!H\K%T7JIRL\ #+"K5MAWGE[T-$N_LN!I6Z!PM#VT3"
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M!U!^D2G5K6+7+RTHCJ1D#[D&SRW9XE=$=!<J1ZSL#83+L7)T8NC(@3;N>Q9
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MJE+CT3N@L6\\_5N5-]%+]1Y.BMK;_-FH1?3DT<[])YMTI:^RE/VF 1-1U#5
MG+:H-?J>K:<@D9X_A: 8&1[=Y[L=A&YG%X<+E56?F4'[*<S?N[JQY,1'GPAM
M98CBAA9U0*+7<?AO?^/RJS*UFEG]+-K'&UK$@_U.H78)?^"-+]IVR3LWJ2_B
M<P]T8O%V+FE45A;-I2^4N06:I-$]75D*U\HXSZB))J-NWI3>C /Q>)GP$M?*
M=2L)K]:V:DLQ]X&2#\D/21@MC1-CNRAEEV7*Z@97=34>V>POH0*7,C1S]Y5S
M39ZUN#'9@'^D=5;^,@?Z?4_)-6?Z]GB1T/[;W11!KWOL,,!BZUZ'4=#>KS/
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M+[#&L1%] H9#/Q)+1?8G2C 1+^U*\[&+* D]]Z,T7[ :-%<O\ H*8BUF(Q!
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M1Y_)&K,>>)W:DH@9#\=,2+Q(:-_ FL6*P\[K0_W6G/74\:=AH2\.1&V51;;
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MF*\IE@-7F/'\+VX_MV)AB#-2/>]BX6RLUSI'KD+P!-=-2.=&Z66G61LG;$=
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ME$=/<4GG>.C*9A.PMW[WJ+SC7*,8VEU_!6[7Z'4M04C'DT>)G-B "C,*<TK
MC\A)'U2@^^1 3QWI<=3;TKC/>"LWW6A#O\><W#?.^@4S>O;9*U\6C]8<X5K
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M\LB/>A=)  "A80$ $    &0Q,#(S,#)D97@S,2YH=&WM?>MSV\:2[W=6\7]
M96NWI"K8B6SG:9]4R;)RHEW'SMHZR9[[#21!"0D)\ "@9.Y??_LYTP,,2$IV
M+'G+M_:>6"0QF$=//W_=_>SG\U]>_OCLY]/C%S^.1\_.S\Y?GOYX^C\/'C\\
M>O8E_P4??RG?)\^>OW[QS^3YWT]>OWS]YF]?_/[SV?GI%_A%,A[![T[RLLWK
M'Y^]./LM>7O^SY>G?_OBNIBUES]\]_#KHOPBR1;%1?FW+Q;YO*6GGOVJ/UMF
M]451/FBKU0]?K=JGB?P]J=JV6O)'\ZIL'S3%_^8_'/F_Y]FR6&Q^."^6>9.\
MRJ^3-]4R@S<=OSS[^ZN_?5$7%Y?PJF?/?SQ]=UE,BC:!A27/OGS^X[,O?\65
MQ29P].@#SF!*6T)3^.6?;\Z.7R1_/WUU>GYV\C9-SEZ=/+RKR;PY?7M^?'[Z
M(GGVT^M7Y^ZT+HLV?]"LLFG^0UE=U]GJBQ^?__/!R^/?WS[[$G_XXYW,]^!X
MF9>S?)9DY2QYDS=MUL(?KZ=M-<GK_R@GS>KI]VGRZ*M'7QTF'WTO__'C\1LX
MSY>GR1E/Y0'_Y^WYZY/_^OGURQ>G;]["K/YQJUUK\W?M@P+67K8_//GWF\T4
MI_8VG[9%5?*,CA[B-!*<<5FNLT7R2YZW17F!GSY,CDO87OIXR1\GU3QI+_.D
M::OIGY?58I;730IOK.G3?,%#XZ]F10U_5'63M%72K*?3'(ZGO:R:/+G&_QV/
M8*N639*_6\$OZ11UF+;.RB9S(\'#ETD%7]3)9-T49=XT2=; SFR255VM\GJQ
M2:;5,D\F.8R0TQ RW31I+K/% KY)+O,%T$K+HZT60,UI N/3GS.@G92FH#]H
M8=_P)3C6\RJK9SB1%VY)/.J\>/<P.8__ F:7)D69%"W\NEKDL!_-M,YQ3>EX
M-,MQ\; 4> &\TLQ8ABZKUDXZ*S<ZY\FZA7&;-L]FG<7A:V K)AL8"S80YU/G
MRZK-<7>6Z[*89K2EL"S8MZL"+\\:R(@W_46^R*XSV+Z_YV5>PXF?5/6JJOF1
ME]GUPUO=H@]*JX\<K;Y=Y=/"$VO#U*J?RE8VP\1*^[F&]0$UPI_R3]R7'$ZI
MF,#.P-GALW 0Q11^- =ZM72%U <;/X4#@!_#GGM*.;G,BCJE#TXNBWR>G+[+
MI^NVN,J3U_,YC"9?_@HO*W!GDH,\0Q(OX?2NB_:2OLU6>$BP&EF$'^0$3K-H
MVSS7K_KD=YC(58I0ILPU@ZG4RXQ&O$(B@1]EL*P_JKIH-SKT[[!M<%5YF .@
MG%D^![*%%>>+ZOIPOSU_WTOH'H<+U]WL8&FR:& )#8R*9X,WRIS;X'6-/AD<
M>7"CX>>7!?\'KD_W?B>?Y/7&G<%ICT?_\6]'3[Y]2D?/>X4??/<41UXW,"JL
M.8>-X.GA9)AK5RT,6ZZ7('^)F-; [6NXZC,O"U+@_3EQ<M@ZW 3\-\B-=T4#
MNXK;<)5-LW):P%V$-\!UO"JJ=0/+CHUV6:R:>\"6'CNV]$J918<Q_5[C?2T]
M,V%BXQ,OYKCPU- _T3WNX&+'O8(?*XUNH0C_"D=0%W#KX7,\@06*4R!3.$28
MX<'15X>\JA).:,GB%+YKBG? % Z^T6]GV::Q\A8GCS<9E,7I94#P!2D 0L0I
M_IN8G5E' J=0M,A&X4MB1<H '+?-WTWS58L$2'K =8'Z@Z-RH4>8<)W_:PW4
M03P"Z#TYP(VA$8C.<'/YQ]F\138, [I'YG6UY*V':=!_A='LNCK*/$[RNBWF
MN.ET>F?EU/Q.CL\\2F_/C!);JQ+;F\GA'5#Y[Y= #ID]QFSV1[6N2SZGK&2-
M+$+$M!\P'%SVD.Y+5 &%]1$%ZJ[XD=WK.E=D//+#NRM"S /O"1UM6:W+:4[\
MU-(?_.F)4EZT1*&+A)G]F9=/';L$*JFN\RN6S_"<3&(F!XKL*3+3QER3]K*H
M\9X\#NX)$9L?"A60_CVY1N(&VQ1H<P'\CK=L!KHB_!IW%W;O&D@$:&K&P\"+
M61ZJVMR;6^\ ]F4\\3,)N0?RYVE5PLN7J"_@4:#N C9#&]^IE#YV&KPH4*KK
MDW$ >[Y$ZSRYS*[@@D]R>(WY@9RL[I(7ZG(YOGQQ]AM85.)Q&(\2^K]G*V V
MFT4>WIE\V;LR^-$JN\@?3.H\^_,!<[<?LL4UG"&Z)I[]_"9Y>_;_X/(]_D*'
M)*?'#__V/?V_+Y+?SUZ<__RW+XZ^^NK?G5%X<OKJ_/3-Q_*(?%#)]L1)MO]>
M5_5Z*48A'_!6BQ _42F%5V<\ZFJ6P.CQZ17<N%H_J]8ML,!R)M0&##$8/2HH
M[!U"]1U^0VJ:J')P-R9D)[YS\@^HMH%QUOA\\B]:&!L%\)U: BFH3B09X7,1
M/LB+T<9]UR+W<(H=OW,J^O,"3@36(UH0T#A2<4\L\:3J]8(7B+LI"WPW!39R
MD2?K52!,C=A 7>R;IZ 4@SD ^XF:$O*_!6A0^0Q4#19T\/4JJY%-T#[!V[)D
MNLAX0?0/7"/\N\EK'$)8:8I<16?;/\6>>1 Y1&!8T5,D@;YE"NE[G)ZE"^3I
MB3@/R)B"4<%&D?.#0V-CIQ1VDP%_K.] O)[-_?3%FY 5"Y*LR+%G]HKQ04S1
MK-2--T:)<MK@\^T2.E41?0^TYZ\=CWE=7X"R]K]$Y6+0DYG(I##LC,$]0($!
M9E<#G)-4J*I.U8+/)NY^$@UF,F+*U!K8[+I)\KBQ\624'6;]GL\[RW_K+YMP
M]>IQ0.=9J;KIUMLIEZ_'-:\O*]"GZGS?&X?_ \^"YI'7NU@_&_!3TM5C%/L0
M].+NL>"?0!-@/6?U)JHITUNZO^CI)4V?7.P40 :I3KA:5479BO$8%[ ?A_J_
M<=1_4I6S->P;S/6YZ$A\"<[M,CJ['_&R6-]#SF<&+'EN7*>HZ)'@JD#!7-==
M*8K4,%VLF7WCCM;YQ7H16#&PE)(9O@@ '7/J%X'^D'73%)YXFSQ?(AU=%DNE
M=;+:9LB SX<X'*^*[C?-FD0-LK=]N-YX%#-,^&VA+:$:R"HO=4'31=48*E]5
MBT5#B@(9L"PYNH(Z.)#K F8>TU,<Q0Y9+?> +W\;\6J\-4;[<TM/KRJ@."(1
M(=J//OWCA_T81M.9\UW-S>P.SH@YE)"21DQ$NXR(-W-?035EA["[S.Q:09T(
MY$GMG:,!'8KD6&8SI$0TI2-1G>")@TSL5]"'FW56.NTWHHAZVU)'^Y+E!UX1
M4.VR1=-3Q$+OSL%$W@:31SV<KP*[^0S7B;MM#Z;^8:=("XTJW[<.&Q!^9&MG
MW5^*;2UO5Z8 MJYLD*S3>9WP^$C% -$M-R>ET8N(R.TZ)>!,\:?3:KE:H/[M
MW/[^+<R<4=%O\5WP?>=M=T#)SQ_&HB_WY)J]QO@)49:['H[1BF!B1@M''T8M
M>O3O@@XD=\@/,:FK-;HF^D'&I'-)QJ/^E6"7B?UA&-D"=:BZ$L'DGZ;%=.?*
M$V,9+3)1(EEQQQ(0#$>I'B;OQXA"-A+=Q?$HW$;UO?E@,*J=S+3HC?G,\YI;
MW7YE'>Y:.L,\\L E!;!$/Y*?SCI!73.SGAOZ!BRFN#V'4:TZW%WF+7Z.'X_#
MH!OMV6K !]6[Q(F]M=^MVB]^Y ,:UK0_)+A'$1B/=.:?W8+OSUA/B.MC>",#
M OF%%-\F^97_%KW[XZF&W]]T^@='A\E/%&\TW*_N(DJ8*3E 28?=]U4F<JG9
M"S[(W+]]> Q*"E_KHAF/CFNX@ NR1OH\=,LHSW6(1$8 S>E(V%]'YTN6ZX:]
MZ")YD-FXJ((+G,!I8H1 CG"W&7[P2%X7@^30*UUXCJP;V4ZQE<8C%#1VEN*F
MXRBU"[/!?^!5C^551<_'D&K ;9*7^;R@[:NNR2 M&5L$WP"?%,<J.06<[FS)
M@&(W(,U2$@Q&@@3+9LZ9)6^K!;RKY<_8)DK9S8"L%V0*#J?PB*(<CSK'=P*'
M!71P<'78/T<6]%9:U/W5X08[K]8T:\3EK&M+U0FV@!-'4R 3-9RBBA3R$I#5
MDH0_?8?FN'$A83@X:UK%0B W!<X7H055_L7^9T_3>.0<W7RDV0IDSS2;+.A0
M\673K*XW_7-)K</.+\T<57A_/\1:;[% D. 9:$RP(-2$0*Q>D<4%6L_V\Y,/
MF<4T:_06%CG?<=(U1"ZC5I*[E>:$1\+]82D_R74'V,SKOI-#>(Y(\H*N)VZF
M[):HC 1M8KW&V6=T]:/T#4,>//%7L:R"WXU'XARH<_00,=@&&$A%-XKC=\QY
MW.T*E65K.W5Y6.P.\(8XUY1C/N&])E:$@69:=\,3)BKQ\!2D"=2+PN.@!QP5
MDR+*-+;Q_F.XV?VM<E";GO;T$2V@<Z(2WO$T%$\=:WT5".^^='-ZIK]B;<58
M$R\B7 0,**M8P=.Y\XA7Y!%O(A>+02<91\0%.H2>MCSP:U3\!<).BAS8[\$W
M7[67/J:>E.2&J^$*[C,,K#.7<;X/QX&Y5[4*OWE1-\@X2EQQXX7@>*00  GX
M@>*,F[2!&>B^AOOW%/2ET"Y!W2=UGPK.@#X4K '/%#ZUP47[WLX)[8$[$-UE
M-Y"' 0I,W:7= %YYJE33=RX)8Y)+3O<.65QEZ ;/^X,>E<PSV WD4S<A+/Z=
M6EI"9>-1E\RVOE.TD,%W8)SX$A%5P9#S:K&HKA67B)\X!_)J/0&^XIS"),:J
M$(-B[5%&@"#)DDDNAV.NF@30AKD 0V'1(=A=6%\Q98[@3<7WY&U'CV^LQF>'
MI&X)@$SB/*#O+7M$*6*3?JPR,_1R5#4J*^Y/\@>J)^"'+6O[9I^E?7?CI16'
M"3MU4&-A-NDE:A4$MIA;&-P:WT ,MRQ(54#I;N138X7='-<=1>F34ET8?)V!
M : V@5O.NH05X&]\:.CHR;&!F[[UZ(13Q30<<V#HZ/O'3P+LVP$^P)A3^UL&
MG1XF!YUP%.^#4K(BG- %+C)\DN-O2QC>H;A) 43GE-,.&U4O<PD"58A#($],
M0 P8TA5_T.'3]R;Z6U &D@9&MJ=UL=)3HS@?39#F#J/S'^CLR<M&<,#P#9TF
M8F]8T0,Y4(KHO@#JQYV @P>5'/><_J*GZ!@5P@$V#9RDL*L5&P?P+ F_1O#:
MH,ZS,>A>Q-0+9X(8W12.I+U&91 Y"\SAHF_PX#A=;<_'TR4&4M0:1$ = Q'L
MBP+>*$'GIJFF]&<J''@\@N6"2E?.> 3F&ZI2R^GS5R;^?I,WR++Y%8Y.4S(9
MJW7[R;K/'G]VG]UZ+V'P1;%4ZZ#+UHE]7U?K!9+[,!.W3/8,>);@\;YZ@M??
M<-V=F7IO'_R79ND!Y2_7BPNR'Z.<VC/HQRDH!8Y#ITG?"0.[]*=R!6-Y*3O8
MZ9KI/.<\,1Y!PRA2O8'T@=X_=6#!1<LE%L/RH\XOB@81HR(]2.B[[![5GQ!X
MY\*J*@1H)+#M'.,GY%]HS]1^"/>B]$Z$ DB%$(_X)QQX&5'0V:Q&8<AG,YO5
MI*+./=<&N<@TL EB&DDWI $O(%:N)[N@>(V+:S"^U\ 2(\-H5*)9K^ S2?G0
M$W"<.>+<>$J/OJ_K^#9;?778BUZ3'-%9=]3*Q&B5@Z&TU(7O,@[0Y*WD ""
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M5<,E6.07&B;-VW;!XFZ5;=@S!CIHCNZ"HEDR'@6>T5"$)JEM?,J!;/G6?48
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MT4D%"";<T2"0E;#^0SEK&;^%*[PP" H[P^AS60-: 9%X6[$[J'=*#,J_!*7
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M3)=@X*P#]TBPKX%G+)>9.#=M94Q&@=PCVHQC/.3US3@NXI5&J1L^'O$ATOT
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M_(4B/9=A@?C8%&>Z6,@%(C\&K*Z$4X^OL'7=CSY9/] WG_U 'P6.1D5;DA=
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M)XL;'5VP:[%RYLCV&N*UCDG6^2+3%A+8NN4.U/3C#@(NDK,N6Q*_!U5]DVN
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M<9H!X[KBYWV>CDGYT1(?VR1K:M(>3,)/UC08^"/^R+7%T&"O1=VCDD6S];1
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MUB3Y?KM)\NS+YZ]?_!,^_/G\EY<__G]02P,$%     @ 6SI/48%UI:>V%
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M]G;;'2,QT6X2?)0SO%&# >'4SU,=#46($P E@?$ LTZ992&8S+Q9P K<3]4
M1YX),X*;ZG"N2YS#: 2J7O.P5AWE](PX3T6H#2&A2IZXG:4R,EA/* *<AFG0
M)C:VA9$P$[V6.(ES;90XQW$"5BIHT,EBD1 R@LP>GRN^'&A #:XD8#N'XY:P
M?-F;\ P5^7:R-HRIQOT&+QO'38Q/?>-,'A&@+5E4C740@%.P;X:$OUZ+<"2A
M"OM  7@!O#"??:42,5(RR$8>N&8WK[Q1% ?Q<(*S2E2:T5[Q\"BB&8F<@*]
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M/7?4\E_D_^\F_WL%E.+^US(4A^OS&:$9S(HBIE%%@Q,X?<J)<C:15$"?1-Y
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MJU??" =WENG_7^(B_]O,?P-02P,$%     @ 6SI/41YO@;!L P  /PP  !$
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MX6+[FM,>ZA8.DGWC5WZ#C.-6_#HW=D<K%HMA1_-KONQV)GC-QXO;>2W9LE"
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MH S+!F%5+?D35_K(_-&7]!1-_O2)/O,?4$L#!!0    ( %LZ3U&J\G3\X00
M -TL   5    ;7EG;BTR,#(P,3 P.5]P<F4N>&ULU9I?;^HV&,;OCW2^@Y=S
MLTE+0J!=!RH]8I1.:+1%P-F_FR.3O( UQT:V*?#M9P=\1"!TI-N9XEZ4X/AY
M_?C].8YC<OMQDU+T D(2SMI>%-0\!"SF"6'SMK>2/I8Q(1Z2"K,$4\Z@[6U!
M>A_OWK^[_<;WT?U#_PGY:*'44K;"<+U>!\F,,,GI2NF0,HAY&B+?M_6[DT_H
MUUUS+30""E@"JM?J-?\:_;0B-&F9+[6;VDU0/Y0)P"8>2K""%HIJ870=FIJH
MT8KJK>LK-'Q$/2P5"(8F)(5#+5]N!9DO%/HV_BYK"]USQH!2V*('PC"+":9H
M;"U_C_HL#E"'4C0R,JE]2A OD 3[J)2POUKFW]2X1^_?(?VG$\ED5MKV3#KV
MV=A,!0VXF&NWM49H1=ZA9G,B6C<R2=1L-L/L;+Z^)$6U=0-1^/OC8!PO(,6^
MAJ"AQ4=-:3>)^J(^-'<=[D[:^I*T9!9IP.,L]Q=T"YVM8;[YMIIOBORH[C>B
M8",3[\XTN<NJX!1&,$/F\].H_Z5-C50)L@D@F6/A<Z8K0S:VLE$0U6K-4.$-
M9SS=AD8;WO-XE0)3]K/#DAY31&W[;,9%FO7(0UER6PL!L[:7;N?,M]&,KP\C
M'>ASF4!JN]07B"3IDH*'PH-^+84>0TQEM0>Z("> C0*60&+#F Y\Y9[?[2CO
MAS*/<YFP5W.&4$(<S/E+F #1+49-<^"; [\6[0%^T$6?NUQ/(YVI5 +'*I\0
M:D80%[:0XBG0ME<@"O][6[NNCV!.3"-,/>$4+G57K,V;/ 3;$7$N,A:QC:H/
M<U1/KY!]C7")A8[GQPL]&5KU3/"T,&'[UOAK?KE(0+2]>CW0$X2'EH)PH:OI
M$@^MI+;$E\8\IN8<S$ (2 :[))PUFSG5DZV$K.97(=?1@S<Q _B!XOFER(Y$
MU65U9-1":C@&:3?DNKH? M.^GL0VO\"VW/5U(JXNM#.&+;PKQ^!U5\*DXH'(
M&-,_ (L>2^[U NOBV?NLOKH(SWNV%*\=HVCO\Q.=STO)Y375I97W:0G=.$IH
M"-IQ4O(B.R.N/K,CPQ;>CX[!LVOGF(LE%UF&QSK1T.4K?1O8=GE2<CWY#Z&J
M"_8B^Q9STTG,#X3"TRJ=@BC']%!7=8"'7O>T&C4G:4WPII_H9) 9V6U1O 7=
MV2!5YWC6N(4:.0FUDR0ZU7+_,2 ,HG) "P-4'6:A:0O2M2?W7)>Z^O!93/B:
MO0GCH=P1B(>6+4(WG^OW'<KN\L]B*/@+,3O*;^%X$L,1F">^+5'7'O9SO1IR
MJ3#]DRS++U^+(SA"\\BU9>G:([^983H"<!EZ>4UU>>5]6D(_.$;(_&A&APO.
M2CY.G.JJ2^K4JZ7EV@;-;]JE M;E:;IB^]6TO!39&7%UN9TQ;.&YMD$SYI3$
M1!$V?]2W:D&,P<O(%2FKBZW(K67FVF[+4( 9?J!75-GVKOGY6SS/9I=/E*]%
MJ"[#UUSO65ZYMA=SU*>^E"L0_YYH01QGN!9XMW1=VY090[PR1J/Z=$(4O7BY
M>:JK+KU3KY:6:SLO$X'-JWOC;3KE%]\&CT35Y71DU$)R;6_%#K?>)EY@-H<R
MKR05:ZN+K-BO)>?F'DHO!3'7X_!GP==JH>?])68EWWDY$Z*Z'%^U;7'^#]LH
MM^%):@:ZP+R5NSMC_IEW3'7)WU!+ 0(4 Q0    ( %LZ3U&?^9C)*QD   RB
M   .              "  0    !D,3 R,S R9#AK+FAT;5!+ 0(4 Q0    (
M %LZ3U$?K56:""P   G*   1              "  5<9  !D,3 R,S R9&5X
M,3 Q+FAT;5!+ 0(4 Q0    ( %LZ3U'($S3/K#,  -88 0 1
M  "  8Y%  !D,3 R,S R9&5X,3 R+FAT;5!+ 0(4 Q0    ( %LZ3U'RR(]Z
M%TD  *%A 0 0              "  6EY  !D,3 R,S R9&5X,S$N:'1M4$L!
M A0#%     @ 6SI/48%UI:>V%   /5,  !$              ( !KL(  &0Q
M,#(S,#)D97@Y.3$N:'1M4$L! A0#%     @ 6SI/41YO@;!L P  /PP  !$
M             ( !D]<  &UY9VXM,C R,#$P,#DN>'-D4$L! A0#%     @
M6SI/4;I/ONJ8!@  /$<  !4              ( !+ML  &UY9VXM,C R,#$P
M,#E?;&%B+GAM;%!+ 0(4 Q0    ( %LZ3U&J\G3\X00  -TL   5
M      "  ?GA  !M>6=N+3(P,C Q,# Y7W!R92YX;6Q02P4&      @ " #\
) 0  #><

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
